<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">89221</article-id>
<article-id pub-id-type="doi">10.7554/eLife.89221</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.89221.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.1</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>PAK3 downregulation induces cognitive impairment following cranial irradiation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Haksoo</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kang</surname>
<given-names>Hyunkoo</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moon</surname>
<given-names>Changjong</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8010-519X</contrib-id>
<name>
<surname>Youn</surname>
<given-names>BuHyun</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Department of Integrated Biological Science, Pusan National University</institution>, Busan 46241, <country>Republic of Korea</country></aff>
<aff id="a2"><label>2</label><institution>Department of Veterinary Anatomy and Animal Behavior, College of Veterinary Medicine and BK21 FOUR Program, Chonnam National University</institution>, Gwangju, 61186, <country>Republic of Korea</country></aff>
<aff id="a3"><label>3</label><institution>Department of Biological Sciences, Pusan National University</institution>, Busan 46241, <country>Republic of Korea</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Ye</surname>
<given-names>Keqiang</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Chinese Academy of Sciences</institution>
</institution-wrap>
<city>Shenzhen</city>
<country>China</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Nelson</surname>
<given-names>Sacha B</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>Brandeis University</institution>
</institution-wrap>
<city>Waltham</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label><bold>Correspondence:</bold> Professor BuHyun Youn, Department of Biological Sciences, Pusan National University, Busandaehak-ro 63beon-gil 2, Geumjeong-gu, Busan 46241, Republic of Korea. Phone: 82-51-510-2264; Fax: 82-51-581-2962; E-mail: <email>bhyoun72@pusan.ac.kr</email></corresp>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2023-09-12">
<day>12</day>
<month>09</month>
<year>2023</year>
</pub-date>
<volume>12</volume>
<elocation-id>RP89221</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2023-06-15">
<day>15</day>
<month>06</month>
<year>2023</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2023-07-01">
<day>01</day>
<month>07</month>
<year>2023</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.06.30.547296"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2023, Lee et al</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Lee et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-89221-v1.pdf"/>
<abstract>
<title>Abstract</title>
<p>Cranial irradiation is used for prophylactic brain radiotherapy as well as treatment of primary brain tumors. Despite its high efficiency, it often induces unexpected side effects, including cognitive dysfunction. Herein, we observed that mice exposed to cranial irradiation exhibited cognitive dysfunction, including altered spontaneous behavior, decreased spatial memory, and reduced novel object recognition. Analysis of actin cytoskeleton revealed that ionizing radiation (IR) disrupted the filamentous/globular actin (F/G-actin) ratio and downregulated the actin turnover signaling pathway p21-activated kinase 3 (PAK3)-LIM kinase 1 (LIMK1)-cofilin. Furthermore, we found that IR could upregulate microRNA-206-3p (miR-206-3p) targeting PAK3. As the inhibition of miR-206-3p through antagonist (antagomiR), IR-induced disruption of PAK3 signaling is restored. In addition, intranasal administration of antagomiR-206-3p recovered IR-induced cognitive impairment in mice. Our results suggest that cranial irradiation-induced cognitive impairment could be ameliorated by regulating PAK3 through antagomiR-206-3p, thereby affording a promising strategy for protecting cognitive function during cranial irradiation, and promoting quality of life in patients with radiation therapy.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>Cranial radiation</kwd>
<kwd>Cognitive impairment</kwd>
<kwd>Dendritic spine</kwd>
<kwd>Intranasal administration</kwd>
<kwd>microRNA</kwd>
<kwd>p21-activated kinase 3</kwd>
</kwd-group>

</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Radiotherapy is an important component of cancer treatment, which utilizes high-energy radiation to damage the DNA of cancer cells and prevent their growth and division <bold>(<xref ref-type="bibr" rid="c8">Brown et al., 2018</xref>; <xref ref-type="bibr" rid="c58">Owonikoko et al., 2014</xref>)</bold>. Over the years, radiotherapy has undergone significant developments to improve its efficacy and minimize its side effects. Nevertheless, some adverse effects of radiotherapy have been reported, including cognitive impairment <bold>(<xref ref-type="bibr" rid="c33">Houillier et al., 2019</xref>; <xref ref-type="bibr" rid="c45">Krull et al., 2018</xref>; <xref ref-type="bibr" rid="c64">Rapp et al., 2015</xref>; <xref ref-type="bibr" rid="c69">Shah et al., 2015</xref>)</bold>. One type of radiotherapy that has been associated with such adverse effects is prophylactic cranial irradiation (PCI), which is used to prevent the spread of cancer to the brain and is commonly administered to patients with certain types of cancer, such as small-cell lung cancer and acute lymphoblastic leukemia, who are at high risk of developing brain metastasis <bold>(<xref ref-type="bibr" rid="c13">Conklin et al., 2012</xref>; <xref ref-type="bibr" rid="c82">Xue et al., 2022</xref>)</bold>. Notably, in the case of small-cell lung cancer, the cumulative risk of brain metastasis within 1 year was 14.6% in the PCI group and 40.4% in the non-PCI group. Accordingly, the 1-year survival rate was 27.1% in the PCI group and 13.3% in the non-PCI group (<ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov">ClinicalTrials.gov</ext-link> number, NCT00016211, <bold>(<xref ref-type="bibr" rid="c72">Slotman et al., 2007</xref>)</bold>). However, it has been reported that the side effects of PCI inevitably affect 50–90% of long-term survivors with permanent and substantial cognitive impairment <bold>(<xref ref-type="bibr" rid="c26">Greene-Schloesser et al., 2013</xref>; <xref ref-type="bibr" rid="c52">Makale et al., 2017</xref>; <xref ref-type="bibr" rid="c66">Rosi et al., 2008</xref>; <xref ref-type="bibr" rid="c84">Zhang et al., 2018</xref>)</bold>. The survivors treated with whole-brain irradiation exhibit severe impairment in memory (54.9%), processing speed (66.3%), and executive function (68.3%) <bold>(<xref ref-type="bibr" rid="c7">Brinkman et al., 2016</xref>; <xref ref-type="bibr" rid="c44">Krull et al., 2013</xref>)</bold>. Moreover, the mechanisms underlying PCI-induced side effects remain poorly understood, and no treatment is currently available to address these adverse effects. Understanding the adverse effects associated with PCI is critical for developing strategies to minimize its impact on the cognitive function of cancer survivors.</p>
<p>Cognition is a complex mental process that involves the acquisition, processing, and application of knowledge <bold>(<xref ref-type="bibr" rid="c28">Harvey, 2019</xref>; <xref ref-type="bibr" rid="c37">Jessen et al., 2020</xref>)</bold>. The frontal cortex and hippocampus are two critical regions of the brain that play a key role in cognition, including memory, attention, and decision-making <bold>(<xref ref-type="bibr" rid="c11">Christensen et al., 2022</xref>; <xref ref-type="bibr" rid="c31">Hogeveen et al., 2022</xref>; <xref ref-type="bibr" rid="c60">Price &amp; Duman, 2020</xref>; <xref ref-type="bibr" rid="c68">Sakimoto et al., 2021</xref>)</bold>. Cognitive impairment is a common feature of many psychiatric diseases, such as schizophrenia <bold>(<xref ref-type="bibr" rid="c25">Gebreegziabhere et al., 2022</xref>; <xref ref-type="bibr" rid="c36">Jauhar et al., 2022</xref>)</bold> and major depressive disorder <bold>(<xref ref-type="bibr" rid="c19">Douglas et al., 2018</xref>; <xref ref-type="bibr" rid="c79">Wen et al., 2022</xref>)</bold>, and can significantly impact an individual’s quality of life. Despite the development of numerous therapies for psychiatric diseases, the limitations of present cure have resulted in cognitive impairment remaining a persistent and unmet need in treating these conditions. Therefore, a deeper understanding of the underlying mechanisms of cognitive impairment is needed to develop more effective treatments and improve patients’ quality of life suffering from these disorders.</p>
<p>Cognition is closely associated with dendritic spine morphology, which plays a key role in synaptic plasticity in the frontal cortex and hippocampus <bold>(<xref ref-type="bibr" rid="c17">Delevich et al., 2020</xref>; <xref ref-type="bibr" rid="c46">Lamprecht, 2021</xref>; <xref ref-type="bibr" rid="c83">Yang et al., 2021</xref>)</bold>. Dendritic spines are small protrusions that extend from the dendrites of neurons and play a critical role in synaptic plasticity, which is the ability of synapses (the junctions between neurons) to change strength and structure in response to experience <bold>(<xref ref-type="bibr" rid="c5">Berry &amp; Nedivi, 2017</xref>)</bold>. Synaptic plasticity is believed to underlie learning and memory processes. The morphology of dendritic spines, which includes their shape, size, and density, is closely linked to synaptic plasticity and can influence cognitive function.<bold>(<xref ref-type="bibr" rid="c34">Huang et al., 2021</xref>; <xref ref-type="bibr" rid="c57">Nakahata &amp; Yasuda, 2018</xref>)</bold> For example, a higher density of dendritic spines in the frontal cortex has been associated with better cognitive function <bold>(<xref ref-type="bibr" rid="c15">Counts et al., 2006</xref>; <xref ref-type="bibr" rid="c17">Delevich et al., 2020</xref>)</bold>, while a decrease in dendritic spine density in the hippocampus has been linked to memory impairment <bold>(<xref ref-type="bibr" rid="c6">Bosch et al., 2014</xref>; <xref ref-type="bibr" rid="c38">Kandimalla et al., 2018</xref>; <xref ref-type="bibr" rid="c75">Szatmari et al., 2021</xref>)</bold>. In neurons, the dendritic spine morphology is closely related to the balance between two forms of the cytoskeletal protein actin: filamentous actin (F-actin) and globular actin (G-actin) <bold>(<xref ref-type="bibr" rid="c30">Hlushchenko et al., 2016</xref>; <xref ref-type="bibr" rid="c49">Lei et al., 2016</xref>)</bold>. F-actin is a rigid, filament-like structure that provides the structural stability required for dendritic spine maturation and synaptic function. G-actin is a monomeric form of actin that serves as the building block for F-actin and is critical for actin dynamics and the formation of new dendritic spines. An appropriate balance between F-actin and G-actin is essential for maintaining dendritic spine structure and function <bold>(<xref ref-type="bibr" rid="c30">Hlushchenko et al., 2016</xref>; <xref ref-type="bibr" rid="c49">Lei et al., 2016</xref>)</bold>. Disruptions in this balance have been linked to cognitive dysfunction in various neurological and psychiatric disorders.</p>
<p>p21-activated kinase 3 (PAK3) is a serine/threonine kinase that plays a critical role in the regulation of dendritic spine morphology and synaptic plasticity <bold>(<xref ref-type="bibr" rid="c12">Combeau et al., 2012</xref>; <xref ref-type="bibr" rid="c76">Thévenot et al., 2011</xref>)</bold>. PAK proteins function as Rac1 and Cdc42-specific effector molecules that mediate cytoskeletal remodeling by regulating LIM kinase (LIMK), oncoprotein 18 (OP18), and tubulin folding cofactor b (TBCB) <bold>(<xref ref-type="bibr" rid="c55">Molli et al., 2009</xref>)</bold>. PAK3 is highly expressed in the brain, particularly in postmitotic neurons of the cerebral cortex and the hippocampus, where it shows a diffuse distribution throughout the soma and proximal dendrites. PAK3-deficient mice exhibit defects in the morphology of dendritic spines, which lead to impairments in synaptic plasticity and cognitive function <bold>(<xref ref-type="bibr" rid="c53">Meng et al., 2005</xref>)</bold>. Several studies have reported that PAK3 is implicated in cognitive impairment in various neurological and psychiatric disorders, including schizophrenia and Alzheimer’s disease (AD) <bold>(<xref ref-type="bibr" rid="c47">Lauterborn et al., 2020</xref>; <xref ref-type="bibr" rid="c56">Morrow et al., 2008</xref>)</bold>. However, the mechanism underlying PAK3-associated cognitive impairment has not yet been fully understood.</p>
<p>In this study, we investigated the impact of cranial irradiation on cognitive function and its underlying mechanisms. Our results demonstrate that ionizing radiation (IR) reduced the level of PAK3, leading to downregulation of PAK3-LIMK1-cofilin signaling, which correlates with the maturation of dendritic spines. We identified that microRNA-206-3p (miR-206-3p) regulates PAK3 and that its antagonist, antagomiR-206-3p, restores PAK3 levels and cognitive function in irradiated mouse models. Our study provides valuable insights into the impact of cranial irradiation on the brain and its potential mechanisms, and a promising strategy to prevent PCI-induced cognitive dysfunction.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Cranial irradiation induces cognitive impairment in mice</title>
<p>Given that cranial irradiation is known to induce cognitive impairment <bold>(<xref ref-type="bibr" rid="c18">Ding et al., 2022</xref>; <xref ref-type="bibr" rid="c45">Krull et al., 2018</xref>; <xref ref-type="bibr" rid="c52">Makale et al., 2017</xref>)</bold>, we first evaluated whether cranial irradiation impaired cognitive function in mice. To assess the effect of IR on cognitive function, we exposed mice to IR. Subsequently, we performed behavioral tests following the overall schedule (<xref rid="fig1" ref-type="fig">Fig. 1A</xref>). A total dose of 60 Gy in 30 fractions is typically delivered to the brain in patients with PCI <bold>(<xref ref-type="bibr" rid="c74">Suwinski, 2021</xref>; <xref ref-type="bibr" rid="c78">Wegner et al., 2019</xref>)</bold>, and previous studies reported that a total dose of 10 Gy caused impaired neurogenesis and cognitive behavior in mice <bold>(<xref ref-type="bibr" rid="c59">Pazzaglia et al., 2020</xref>; <xref ref-type="bibr" rid="c62">Raber et al., 2004</xref>)</bold>. In this regard, mice were irradiated with five fractions of 2 Gy administered to the cranial region <bold>(<xref ref-type="bibr" rid="c9">Ceyzériat et al., 2021</xref>; <xref ref-type="bibr" rid="c80">Wilson et al., 2020</xref>)</bold>. Individual behavioral tests, such as the open field test (OPF), Y-maze, and novel object recognition test (NOR), were performed from days 3 to 8 post-IR. In mice treated with IR, spontaneous alteration and time in the novel arm were significantly reduced by 66.67 and 58.14%, respectively (<xref rid="fig1" ref-type="fig">Fig. 1B</xref> and <xref rid="fig1" ref-type="fig">1C</xref>). The time spent with objects did not differ between familiar and novel objects in IR-treated mice (<xref rid="fig1" ref-type="fig">Fig. 1C</xref>). Our previous study has shown that IR can induce depression-like behavior <bold>(<xref ref-type="bibr" rid="c41">Kim et al., 2022</xref>)</bold>. IR-treated mice exhibited reduced time in the center of the OPF, thereby indicating depressive-like behavior (<xref rid="figs1" ref-type="fig">Fig. S1A</xref>). Based on the findings in the OPF, IR partially induced depression-like behavior, but the total distance traveled did not differ. These results indicate that IR could impair cognitive function and that depressive-like behavior does not impact overall moving behavior.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Fig 1.</label>
<caption><title>Cranial irradiation affects cognitive function and the maturation of dendritic spine</title>
<p><bold>(A)</bold> A scheme illustrating the schedule of ionizing radiation (IR) and overall behavioral tests. (<bold>B)</bold> The results of spontaneous alteration (left) and spatial memory test (right) after IR using Y-maze. The parameters of spontaneous alteration and spatial memory are described in methods. (<bold>C)</bold> The result of novel object recognition test after IR. (<bold>D)</bold> Left: representative fluorescence image of filamentous actin (F-actin, green) after IR in cortical neuron. Right: The density and distribution of dendritic spine in IR group compared to control group. Scale bars, 10 μm. <bold>(E)</bold> The alterations of F/G-actin ratio after IR in cortical neuron, frontal cortex, and hippocampus. Statistical analysis was performed with Student’s t test for (<bold>B</bold>, left of <bold>C</bold>, and <bold>E</bold>) and one-way ANOVA plus a Tukey’s multiple comparisons test for (right of <bold>C</bold> and <bold>D</bold>). ns, non-significant; *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001; ****p &lt; 0.0001.</p></caption>
<graphic xlink:href="547296v1_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Synapse formation on dendrites is known to impact cognitive behavior <bold>(<xref ref-type="bibr" rid="c1">Arendt, 2009</xref>; <xref ref-type="bibr" rid="c3">Baloyannis, 2009</xref>)</bold>. Therefore, we examined changes in the dendritic spines of the cortical neurons after IR exposure. Cortical neurons were treated with a single 2 Gy at 14 days <italic>in vitro</italic> (DIV). Dendritic spine density did not differ between the non-IR and IR groups. In IR-treated neurons, mature dendritic spines (mushroom) were significantly decreased by 37.5%, whereas immature dendritic spines (filopodia) were increased by 37.14% (<xref rid="fig1" ref-type="fig">Fig. 1D</xref>). The maturation of dendritic spines depends on the F/G-actin ratio <bold>(<xref ref-type="bibr" rid="c10">Chen et al., 2007</xref>; <xref ref-type="bibr" rid="c65">Rex et al., 2009</xref>)</bold>. Accordingly, we evaluated whether IR can impact the F/G-actin ratio in neurons. Exposure to IR decreased the F/G-actin ratio in cortical neurons (21.05%), frontal cortex (21.74%), and hippocampus (73.91%) (<xref rid="fig1" ref-type="fig">Fig. 1E</xref>). Overall, these results indicated that IR could induce cognitive impairment by disrupting dendritic spine maturation.</p>
</sec>
<sec id="s2b">
<title>IR decreases PAK3-LIMK1-cofilin signaling</title>
<p>To identify the molecular mechanism of IR-induced dendritic spine alteration, we analyzed microarray data from the brains of mice treated or un-treated with cranial radiation, which was generated in a previous study (GSE94440) <bold>(<xref ref-type="bibr" rid="c40">Kang et al., 2018</xref>)</bold>. Among the 15 coding genes that were up- and downregulated by cranial irradiation, we focused on the PAK3 gene, which showed a 0.5-fold altered expression in the irradiated brain, considering both the “synapse organization” and the “dendritic spine development” ontologies (<xref rid="fig2" ref-type="fig">Fig. 2A</xref>). In addition, PAK3 is mainly expressed in the frontal cortex and hippocampus, both crucial regions for cognitive function in the brain (<xref rid="figs2" ref-type="fig">Fig. S2A</xref>) <bold>(<xref ref-type="bibr" rid="c11">Christensen et al., 2022</xref>; <xref ref-type="bibr" rid="c60">Price &amp; Duman, 2020</xref>)</bold>. As shown in <xref rid="fig2" ref-type="fig">Fig. 2b</xref>, IR decreased mRNA and protein levels of PAK3 in cortical neurons (49.48% and 44.30%, respectively). In addition, IR decreased mRNA level of PAK3 in frontal cortex (61.67%) and hippocampus (66.67%) (<xref rid="figs2" ref-type="fig">Fig. S2B</xref>). Based on immunocytochemistry data, PAK3 was localized on dendrites in cortical neurons (<xref rid="fig2" ref-type="fig">Fig. 2C</xref>). These results suggested that PAK3, which is correlated with synapses and dendritic spines, is a candidate for IR-induced dendritic spine alteration.</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Fig 2.</label>
<caption><title>IR decreases phosphorylation of LIMK1 and Cofilin via PAK3 downregulation</title>
<p><bold>(A)</bold> The heatmap for the expression of genes in the term “synapse organization” and “dendritic spine development” in the irradiated brain. (<bold>B)</bold> The changes of PAK3 mRNA and protein levels after IR in cortical neuron. Each western blot bands are quantified by ImageJ. (<bold>C)</bold> Representative fluorescence image of F-actin (green) and PAK3 (red) in cortical neuron. Scale bars, 10 μm. (<bold>D)</bold> Schematic illustration of PAK3-LIMK1-cofilin signaling. (<bold>E)</bold> Left: the protein levels of phosphorylated LIMK1, LIMK1, phosphorylated cofilin, and cofilin after IR in cortical neuron. Right: each western blot bands are quantified by ImageJ. (<bold>F</bold>-<bold>G)</bold> Representative fluorescence image of F-actin (green) and phosphorylated LIMK1 (<bold>F</bold>, red) or phosphorylated cofilin (<bold>G</bold>, red) in cortical neuron. Scale bars, 10 μm. Statistical analysis was performed with Student’s t test. ns, non-significant; **p &lt; 0.01; ***p &lt; 0.001; ****p &lt; 0.0001.</p></caption>
<graphic xlink:href="547296v1_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Given that PAK3 inhibits severing and promotes the branching of F-actin <bold>(<xref ref-type="bibr" rid="c63">Rane &amp; Minden, 2014</xref>)</bold>, we further examined actin dynamics-related PAK3 signaling. PAK3 phosphorylates LIMK1 to activate it, and activated LIMK1, in turn, phosphorylates cofilin to its inactive state. Activated cofilin promotes actin turnover, while inactivated cofilin suppresses actin turnover (<xref rid="fig2" ref-type="fig">Fig. 2D</xref>) <bold>(<xref ref-type="bibr" rid="c4">Bamburg et al., 2021</xref>; <xref ref-type="bibr" rid="c20">Edwards et al., 1999</xref>)</bold>. Therefore, we examined whether IR can affect the activation of LIMK1 and cofilin. Herein, we observed that IR decreased the expression of phosphorylated LIMK1 and cofilin in cortical neurons, frontal cortex, and hippocampus (<xref rid="fig2" ref-type="fig">Fig. 2E</xref> and S2C). In addition, phosphorylated LIMK1 and cofilin were less expressed and localized on the dendrites in cortical neurons (<xref rid="fig2" ref-type="fig">Fig. 2G</xref> and <xref rid="fig2" ref-type="fig">H</xref>). These results suggested that IR could decrease the activation and localization of LIMK1 and cofilin in dendritic spines by downregulating PAK3 expression. However, IR did not alter other downstream factors related to cytoskeleton regulation, such as oncoprotein 18 (OP18) and tubulin-folding cofactor B (TBCB) (<xref rid="figs3" ref-type="fig">Fig. S3A</xref> and <xref rid="figs3" ref-type="fig">S3B</xref>). Overall, these results showed that IR decreased the expression and localization of PAK3, which, in turn, decreased the phosphorylation of LIMK1 and cofilin.</p>
</sec>
<sec id="s2c">
<title>PAK3 regulates dendritic spine morphology and maturation</title>
<p>Given that PAK3 is associated with synapse organization and dendritic spine development, we further examined whether the regulation of PAK3 could impact dendritic spines. First, we knocked down PAK3 using a short hairpin RNA (shRNA). Every two shRNAs targeting PAK3 successfully reduced the mRNA level of PAK3 by approximately 30% (<xref rid="fig3" ref-type="fig">Fig. 3A</xref>). We employed shRNA #1 to examine the effects of PAK3 downregulation. Downregulated PAK3 expression reduced the F/G-actin ratio (<xref rid="fig3" ref-type="fig">Fig. 3B</xref>) and LIMK1-cofilin signaling (<xref rid="fig3" ref-type="fig">Fig. 3C</xref>). Dendritic spines were observed after PAK3 downregulation. We noted that the dendritic spine density did not differ between the control and PAK3 downregulation groups. However, the number of mushroom spines was lower than that of filopodia following PAK3 downregulation (<xref rid="fig3" ref-type="fig">Fig. 3D</xref>). Compared with the filopodia spine, the mushroom spine is a more mature form that typically transmits nerve signals to other neurons <bold>(<xref ref-type="bibr" rid="c29">Hering &amp; Sheng, 2001</xref>)</bold>. We examined the effects of PAK3 overexpression (<xref rid="fig3" ref-type="fig">Fig. 3E</xref>). PAK3 overexpression affects the expression and phosphorylation of LIMK1 and cofilin. We evaluated the recovery of IR-induced downregulated PAK3 signaling after PAK3 overexpression. Notably, PAK3 overexpression could restore IR-induced downregulation of F/G-actin (<xref rid="fig3" ref-type="fig">Fig. 3F</xref>). Following alterations in the F/G-actin ratio, mushroom spines were more abundant than filopodia in IR-treated PAK3 overexpressing neurons (<xref rid="fig3" ref-type="fig">Fig. 3G</xref>). These results suggested that PAK3 could regulate the F/G-actin ratio and maturation of dendritic spine through LIMK1-cofilin signaling. Considering IR-induced decreased PAK3 signaling, upregulation of PAK3 expression could restore the F/G-actin ratio and dendritic spine distribution to normal levels in murine neuron.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Fig 3.</label>
<caption><title>PAK3 regulates F/G-actin and dendritic spine in neuron</title>
<p><bold>(A)</bold> The changes of PAK3 mRNA levels after PAK3 downregulation (shPAK3) in cortical neuron. (<bold>B)</bold> The F/G-actin ratio after expression of PAK3 downregulation (shPAK3) in cortical neuron. Each F-actin and G-actin are quantified by ImageJ. (<bold>C)</bold> The protein levels of phosphorylated LIMK1, LIMK1, phosphorylated cofilin, and cofilin after PAK3 downregulation (shPAK3) in cortical neuron. (<bold>D)</bold> Upper: representative fluorescence image of filamentous actin (F-actin, green) after PAK3 downregulation (shPAK3) in cortical neuron. Lower: the density and distribution of dendritic spine in shPAK3 group compared to control group. Scale bars, 10 μm. <bold>(E)</bold> The protein levels of PAK3, phosphorylated LIMK1, LIMK1, phosphorylated cofilin, and cofilin after PAK3 overexpression in cortical neuron. (<bold>F)</bold> The F/G-actin ratio after IR or IR with PAK3 overexpression in cortical neuron. Each F-actin and G-actin are quantified by ImageJ. (<bold>G)</bold> Upper: representative fluorescence image of filamentous actin (F-actin, green) after IR and/or PAK3 overexpression in cortical neuron. Lower: the density and distribution of dendritic spine in control, IR and/or PAK3 overexpression group. Scale bars, 10 μm. Statistical analysis was performed with Student’s t test for (<bold>B</bold> and <bold>D</bold>) and one-way ANOVA plus a Tukey’s multiple comparisons test for (<bold>A</bold>, <bold>D</bold>, <bold>F</bold>, and <bold>G</bold>). ns, non-significant; *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001; ****p &lt; 0.0001.</p></caption>
<graphic xlink:href="547296v1_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>To explore whether IR can decrease PAK3 signaling and dendritic spine maturation in human neurons, we differentiated neural progenitor cells into neurons. Herein, we observed that the expression of stemness markers (SOX2, Nestin, and PAX6) was decreased in differentiated neurons (<xref rid="figs4" ref-type="fig">Fig. S4A</xref>). In addition, the expression of neuronal (NeuN) and synaptic (PSD95) markers were increased in differentiated neurons when compared with that in neural progenitor cells (<xref rid="figs4" ref-type="fig">Fig. S4B</xref>). The altered expression of markers suggests that human neural progenitor cells can differentiate into human neurons. Therefore, differentiated neurons were used to confirm alterations in human neurons. In human neurons, IR reduced the F/G-actin ratio (<xref rid="fig4" ref-type="fig">Fig. 4A</xref>). Based on IR-induced altered F/G-actin ratio, we hypothesized that IR could reduce PAK3-LIMK1-cofilin signaling in differentiated neurons. IR decreased the expression of PAK3, phosphorylated-LIMK1, and phosphorylated-cofilin in human neurons (<xref rid="fig4" ref-type="fig">Fig. 4B</xref> and <xref rid="fig4" ref-type="fig">C</xref>). A previous study has revealed that IR can reduce mature dendritic spines and enhance immature dendritic spines (<xref rid="fig1" ref-type="fig">Fig. 1D</xref>); IR downregulated the mature dendritic spine and upregulated the immature dendritic spine in human neurons (<xref rid="fig4" ref-type="fig">Fig. 4D</xref>). To confirm that these changes were caused by IR-induced PAK3 downregulation, we used shRNA to downregulate PAK3 expression in differentiated neurons. Consistent with the IR effect on dendritic spines, downregulated PAK3 expression increased the number of immature dendritic spines (<xref rid="fig4" ref-type="fig">Fig. 4E</xref>). Collectively, PAK3 signaling is essential for the maturation of dendritic spines, and IR could disrupt PAK3 signaling in human neurons.</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Fig 4.</label>
<caption><title>IR decreases PAK3-LIMK1-Cofilin signaling in differentiated human neuron</title>
<p><bold>(A)</bold> The F/G-actin ratio after IR in differentiated neuron. Each F-actin and G-actin are quantified by ImageJ. (<bold>B)</bold> The mRNA level of PAK3 after IR in differentiated neuron. (<bold>C)</bold> The protein levels of PAK3, phosphorylated LIMK1, LIMK1, phosphorylated cofilin, and cofilin after IR in differentiated neuron. (<bold>D)</bold> Upper: representative fluorescence image of filamentous actin (F-actin, green) after IR in differentiated neuron. Lower: the density and distribution of dendritic spine in IR group compared to control group. Scale bars, 10 μm. (<bold>E)</bold> Upper: representative fluorescence image of filamentous actin (F-actin, green) after PAK3 downregulation (shPAK3) in differentiated neuron. Lower: the density and distribution of dendritic spine in shPAK3 group compared to control group. Scale bars, 10 μm. Statistical analysis was performed with Student’s t test for (<bold>A</bold>, <bold>B</bold>, <bold>D</bold>, and <bold>E</bold>) and one-way ANOVA plus a Tukey’s multiple comparisons test for (<bold>D</bold> and <bold>E</bold>). ns, non-significant; **p &lt; 0.01; ***p &lt; 0.001; ****p &lt; 0.0001.</p></caption>
<graphic xlink:href="547296v1_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2d">
<title>IR-induced miR-206-3p decreases PAK3 expression, and its inhibition rescued PAK3 signaling</title>
<p>To elucidate the mechanism underlying IR-induced changes in PAK3 expression, we performed a luciferase reporter assay for the PAK3 promoter. In murine neurons, IR failed to induce any change in luciferase activity (<xref rid="fig5" ref-type="fig">Fig. 5A</xref>), suggesting that IR does not induce PAK3 expression by regulating transcription levels. Next, we hypothesized that IR might alter the miRNAs targeting PAK3. Using miRNA databases (miRDB, TargetScan, and TarBase), we analyzed miRNAs targeting PAK3, selecting three miRNA candidates (<xref rid="fig5" ref-type="fig">Fig. 5B</xref>). Among the three miRNAs, IR significantly upregulated only miR-206-3p in both mice and humans (<xref rid="fig5" ref-type="fig">Fig. 5C</xref>). To validate whether IR can impact miR-206-3p expression and examine the effects of miR-206-3p inhibition, we determined miR-206-3p levels after IR and treatment with an inhibitor of miR-206-3p (antagomiR-206-3p). IR increased miR-206-3p expression in both mouse and human neurons (<xref rid="fig5" ref-type="fig">Fig. 5D</xref>). In addition, antagomiR-206-3p successfully inhibited IR-induced miR-206-3p expression in mouse and human neurons (<xref rid="fig5" ref-type="fig">Fig. 5D</xref>). Consistent with the miRNA inhibition data, IR-induced PAK3 downregulation was restored to approximately 90% of the control in both neurons (<xref rid="fig5" ref-type="fig">Fig. 5E</xref>). To confirm whether miR-206-3p could affect PAK3 signaling, we examined whether treatment with miR-206-3p could alter PAK3-LIMK1-cofilin signaling. As expected, miR-206-3p decreased PAK signaling, and the respective antagonist partially restored the downregulated PAK3 signaling (<xref rid="fig5" ref-type="fig">Fig. 5F</xref> and <xref rid="fig5" ref-type="fig">5G</xref>). In addition, consistent with the effects of antagomiR, IR disrupted the distribution of dendritic spines, and IR with antagomiR treatment restored dendritic spine maturation (<xref rid="fig5" ref-type="fig">Fig. 5H</xref>). These results suggested that IR-induced miR-206-3p decreased PAK3 signaling and dendritic spine maturation in mouse and human neurons.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Fig 5.</label>
<caption><title>IR-induced miR-206-3p affects PAK3-LIMK1-cofilin signaling</title>
<p><bold>(A)</bold> The relative luciferase activity of PAK3 promoter after IR in cortical neuron. (<bold>B)</bold> Venn diagram of predictable PAK3-targeting miRNAs from databases (miRDB, TargetScan, and TarBase). (<bold>C)</bold> The relative miRNA expression of 3 overlapped miRNAs after IR in cortical neuron and differentiated neuron. (<bold>D)</bold> The relative miRNA expression of miR-206-3p after IR and/or antagomiR-206-3p treatment in cortical neuron and differentiated neuron. (<bold>E)</bold> The mRNA level of PAK3 after IR and/or treatment of antagomiR-206-3p in cortical neuron and differentiated neuron. (<bold>F)</bold> The protein levels of PAK3, phosphorylated LIMK1, LIMK1, phosphorylated cofilin, and cofilin after treatment of miR-206-3p mimic in differentiated neuron. (<bold>G)</bold> The protein levels of PAK3, phosphorylated LIMK1, LIMK1, phosphorylated cofilin, and cofilin after IR and/or treatment of antagomiR-206-3p in differentiated neuron. (<bold>H)</bold> Upper: representative fluorescence image of filamentous actin (F-actin, green) after IR and/or treatment of antagomiR-206-3p in cortical neuron. Lower: the density and distribution of dendritic spine in control, IR and/or treatment of antagomiR-206-3p group. Scale bars, 10 μm. Statistical analysis was performed with Student’s t test for <bold>A</bold> and one-way ANOVA plus a Tukey’s multiple comparisons test for the others. ns, non-significant; ***p &lt; 0.001; ****p &lt; 0.0001.</p></caption>
<graphic xlink:href="547296v1_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2e">
<title>Intranasal administration of antagomiR-206-3p rescues cognitive function</title>
<p>Given that antagomiR for miR-206-3p effectively attenuated IR-mediated alterations in dendritic spines, we next inhibited miR-206-3p to recover cognitive impairment <italic>in vivo</italic>. To efficiently deliver antagomiR to the brain, antagomiR was administered intranasally. Intranasal administration is a less invasive method for drug delivery, easily accessible to adult and pediatric patients. According to the previous <italic>in vivo</italic> experimental protocol (<xref rid="fig1" ref-type="fig">Fig. 1A</xref>), mice were exposed to IR with five fractions (over a 24 h interval) of 2 Gy to the cranial region and subsequently treated with antagomiR via intranasal administration. Then, OPF, Y-maze, and NOR tests were performed from days 2–7 post-intranasal administration. Behavioral tests were performed according to the overall schedule (<xref rid="fig6" ref-type="fig">Fig. 6A</xref>). We then administered Cy5-labeled antagomiR to IR-treated mice via intranasal administration (<xref rid="fig6" ref-type="fig">Fig. 6B</xref>). To validate the delivery efficiency of antagomiR, we examined Cy5 fluorescence in the brain after intranasal administration (<xref rid="fig6" ref-type="fig">Fig. 6C</xref>). Treatment with Cy5-antagomiR treatment dose-dependently increased Cy5 fluorescence. As the frontal cortex and hippocampus are cognition-related central regions in the brain <bold>(<xref ref-type="bibr" rid="c11">Christensen et al., 2022</xref>; <xref ref-type="bibr" rid="c31">Hogeveen et al., 2022</xref>; <xref ref-type="bibr" rid="c60">Price &amp; Duman, 2020</xref>; <xref ref-type="bibr" rid="c68">Sakimoto et al., 2021</xref>)</bold>, we confirmed IR and antagomiR effects in the frontal cortex and hippocampus. Consistent with <italic>in vitro</italic> results (<xref rid="fig5" ref-type="fig">Fig. 5D</xref>), antagomiR decreased the IR-induced miR-206-3p expression in the frontal cortex and hippocampus (<xref rid="fig6" ref-type="fig">Fig. 6D</xref>). IR-treated mice administered antagomiR exhibited attenuated spontaneous alteration, as well as time in the novel arm and time spent with the novel object (<xref rid="fig6" ref-type="fig">Fig. 6E</xref> and <xref rid="fig6" ref-type="fig">6F</xref>). In addition, time spent in the center of the OPF was restored in IR-treated mice administered antagomiR (<xref rid="figs5" ref-type="fig">Fig. S5A</xref> and <xref rid="figs5" ref-type="fig">S5B</xref>). These results showed that antagomiR could successfully attenuate IR-induced cognitive impairment. To validate whether antagomiR-induced recovery of cognitive function is mediated via the restoration of PAK3 signaling to normal levels, we confirmed that antagomiR restored IR-induced downregulation of PAK3 signaling. Consistently, antagomiR treatment increased the expression of PAK3, phosphorylated-LIMK1, and phosphorylated-cofilin in the frontal cortex and hippocampus (<xref rid="fig6" ref-type="fig">Fig. 6G</xref>). In addition, the F/G-actin ratio in the frontal cortex and hippocampus was restored to normal when compared with that in the IR-treated group (<xref rid="fig6" ref-type="fig">Fig. 6H</xref>). Collectively, these results suggested that antagomiR could be an effective strategy for IR-induced cognitive impairment by restoring PAK3 signaling.</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Fig 6.</label>
<caption><title>Intranasal administration of antagomiR-206-3p recovers PAK3 signaling and cognitive impairment after IR</title>
<p><bold>(A)</bold> A scheme illustrating the schedule of IR and antagomiR-206-3p treatment and overall behavioral tests. (<bold>B)</bold> Schematic illustration of antagomir-206-3p delivery via intranasal administration. (<bold>C)</bold> The fluorescence images and relative units of cy5-antagomiR-206-3p in the brain of mice 24 h after intranasal administration. (<bold>D)</bold> The relative miRNA expression of miR-206-3p after IR and/or antagomiR-206-3p treatment in frontal cortex and hippocampus. (<bold>E)</bold> The results of spontaneous alteration (left) and spatial memory test (right) after IR and/or antagomiR-206-3p using Y-maze. The parameters of spontaneous alteration are described in methods. (<bold>F)</bold> The result of novel object recognition test after IR and/or antagomiR-206-3p. (G) The protein levels of PAK3, phosphorylated LIMK1, LIMK1, phosphorylated cofilin, and cofilin after IR and/or treatment of antagomiR-206-3p in frontal cortex and hippocampus. (H) The alterations of F/G-actin ratio after IR and/or treatment of antagomiR-206-3p in frontal cortex and hippocampus. Statistical analysis was performed with one-way ANOVA plus a Tukey’s multiple comparisons test. ns, non-significant; **p &lt; 0.01; ***p &lt; 0.001; ****p &lt; 0.0001.</p></caption>
<graphic xlink:href="547296v1_fig6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>Radiotherapy is a common treatment for cancer to stop or prevent cancer cells from growing or spreading in the body. In particular, PCI is widely used for preventing brain metastasis, but it may cause side effects including cognitive impairment, which significantly impacts quality of life of patients. In this study, we investigated the effect of cranial irradiation on cognitive function and the underlying mechanisms in a mouse model. Our results revealed that cranial irradiation reduced cognitive function and downregulated the expression of PAK3, a gene involved in dendritic spine development and synaptic plasticity in the frontal cortex and hippocampus. We demonstrated that the PAK3-LIMK1-cofilin signaling pathway was affected by IR, leading to dendritic spine maturation impairment. Additionally, we found that miR-206-3p regulated PAK3 expression and that antagomiR-206-3p treatment restored PAK3 levels and cognitive function in the irradiated mice. Our findings suggest that PAK3 may play a critical role in cognitive function after cranial irradiation, highlighting a potential therapeutic target to mitigate the adverse effects of radiotherapy (<xref rid="figs6" ref-type="fig">Fig. S6</xref>).</p>
<p>PAK3 expression is altered in several neurodegenerative diseases, suggesting that the decrease in PAK3 may be partly involved in cognitive or developmental symptoms. PAK3 mRNA levels are significantly reduced in the hippocampus of subjects affected with depression <bold>(<xref ref-type="bibr" rid="c23">Fuchsova et al., 2016</xref>)</bold>. Additionally, post-mortem brains of Down syndrome and AD patients, PAK3 proteins are markedly reduced with abnormal cofilin activation in neurites <bold>(<xref ref-type="bibr" rid="c47">Lauterborn et al., 2020</xref>)</bold>. Consistent with our study, decreased PAK3 impairs cognitive function via regulation of dendritic spine in neurodegenerative diseases. In addition to dendritic spine morphology regulation, PAK3 involves in synaptic transmission and trafficking. For example, PAK3 controls the surface trafficking of the major excitatory receptor GluA1 AMPA receptor subunit in neurons <bold>(<xref ref-type="bibr" rid="c35">Hussain et al., 2015</xref>)</bold>. PAK3 can also control synaptic GABA(A)R surface stability via G protein-coupled receptor kinase interacting ArfGAP 1/βPIX signaling <bold>(<xref ref-type="bibr" rid="c73">Smith et al., 2014</xref>)</bold>. These results suggest that PAK3 plays a key role in regulating synaptic function as well as the dendritic spine morphology.</p>
<p>Previous studies have shown that the activation of PAK3 is primarily regulated by phosphorylation <bold>(<xref ref-type="bibr" rid="c50">Liu et al., 2021</xref>; <xref ref-type="bibr" rid="c81">Wu &amp; Jiang, 2022</xref>)</bold>, and phosphorylated PAK3 is correlated to activity of AMPA receptor <bold>(<xref ref-type="bibr" rid="c35">Hussain et al., 2015</xref>)</bold>, neuroplasticity <bold>(<xref ref-type="bibr" rid="c42">Kim et al., 2017</xref>)</bold>, spine morphogenesis <bold>(<xref ref-type="bibr" rid="c85">Zhang et al., 2005</xref>)</bold>, and neurite outgrowth <bold>(<xref ref-type="bibr" rid="c71">Shin et al., 2006</xref>)</bold>. On the contrary, our study demonstrated that a decrease in PAK3 expression alone can significantly alter spine morphogenesis. This finding suggests that PAK3 expression levels may be a critical determinant of dendritic spine development and synaptic plasticity, even regardless of the phosphorylation status. Furthermore, our study identifies a potential mechanism underlying the cognitive impairment associated with cranial irradiation, which downregulates PAK3 expression. These results highlight the importance of PAK3 expression in cognitive function and provide a potential therapeutic target for reducing the adverse effects of cranial irradiation on brain function.</p>
<p>Intranasal administration can bypass blood-brain barrier and rapidly deliver drugs from the nasal mucosa to the brain with a non-invasive way and reducing systemic side effects <bold>(<xref ref-type="bibr" rid="c14">Corrigan et al., 2015</xref>; <xref ref-type="bibr" rid="c77">Tucker et al., 2018</xref>)</bold>. Recent studies reported that intranasal insulin administration for the treatment of CNS disorders including mild cognitive impairment and AD (<ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov">ClinicalTrials.gov</ext-link> Identifier: NCT01767909, <bold>(<xref ref-type="bibr" rid="c16">Craft et al., 2020</xref>)</bold>). Additionally, previous studies reported that intranasal administration of microRNA is effective to ischemic brain injury <bold>(<xref ref-type="bibr" rid="c48">Lawson et al., 2022</xref>)</bold>, depression <bold>(<xref ref-type="bibr" rid="c27">Guan et al., 2021</xref>)</bold>, and AD <bold>(<xref ref-type="bibr" rid="c51">Mai et al., 2019</xref>)</bold>. In this study, we demonstrated the potential utility of intranasal administration of antagomiR-206-3p for restoring PAK3 levels and cognitive function in irradiated mouse models with marginal side effects. Other advantages of intranasal administration include avoiding the gastrointestinal tract or hepatic metabolism <bold>(<xref ref-type="bibr" rid="c54">Mistry et al., 2009</xref>)</bold>, and enhancing drug bioavailability and stability <bold>(<xref ref-type="bibr" rid="c61">Quintana et al., 2016</xref>)</bold>. A previous study reported that drug absorption through nasal cavity is more efficient than through gastrointestinal tract <bold>(<xref ref-type="bibr" rid="c24">Furubayashi et al., 2007</xref>)</bold>. In addition, intranasal administration of biomacromolecular agents, including nucleic acid-based drugs, remarkably reduced the degradation rate and increased the delivery efficiency compared to the oral route <bold>(<xref ref-type="bibr" rid="c22">Fortuna et al., 2014</xref>)</bold>. Collectively, intranasal administration provides a promising avenue for targeting and delivery to the brain with little adverse effects.</p>
<p>Overall, our study highlights the detrimental effects of cranial irradiation on cognitive function and provides new insights into the role of PAK3 in dendritic spine development and cognitive function. We provide the underlying mechanisms of PAK3-associated cognitive impairment after radiotherapy using both differentiated human neurons and mouse models. Considering the high delivery efficiency and the anti-cognitive impairment effects of antagomiR-206-3p from our preclinical results, intranasal administration of antagomiR-206-3p may offer a promising approach for reducing the adverse effects of PCI.</p>
</sec>
<sec id="s4">
<title>Materials and methods</title>
<sec id="s4a">
<title>Mice</title>
<p>Male mice, aged 7[weeks, were used in this study. All experiments were performed in accordance with the provisions of the NIH Guide for the Care and Use of Laboratory Animals. The mice were housed individually or in groups of up to five in sterile cages, and were maintained in animal care facilities in a temperature regulated room (23 ± 1[) with a 12 h light–dark cycle. All animals were fed water and standard mouse chow <italic>ad libitum</italic>.</p>
</sec>
<sec id="s4b">
<title>Irradiation</title>
<p>The animals were anaesthetized by an intraperitoneal (i.p.) injection of zoletil (5 mg/10 g). After sufficient anesthesia was induced, the mice were attached to a fixed plate, and irradiation was applied at locations ranging from 0.3 cm behind the eyes to the posterior part of both ears to ensure that the radiation surface did not involve the eyes, mouth, and spinal cord (to prevent the normal exercise ability of the mouse from being affected by irradiation). The brain of mice were irradiated with 2 Gy daily for five days at a dose rate of 600 MU/min using a TrueBeam STx.</p>
</sec>
<sec id="s4c">
<title>Behavior: Open field test</title>
<p>Depressive-like behavior of mice were assessed in rectangular chambers (Width x Length x Depth = 50 cm × 50 cm × 38 cm). Mice were habituated for 3 min in the chamber (without recording) then placed for another 5 min in center of the chamber (with recording). Localization was recorded and analyzed by the time in center zone using Noldus EthoVision XT software (Noldus Information Technology, Leesburg, VA).</p>
</sec>
<sec id="s4d">
<title>Behavior: Y-maze</title>
<p>Spontaneous alteration was measured using a Y-maze apparatus (three grey opaque plastic, symmetrical arm, length: 40 cm, arm bottom width: 3 cm, arm upper width: 13 cm, height of wall: 15 cm, angled at 120°, Busan, South Korea). Each mouse was placed in the central area. The number of entries into the arms and alterations were recorded for 10 min with the EthoVisionXT video-imaging system. Max alternation was defined as the number of possible alternations counted by the total number of arms entered minus 2. Alternation was defined as consecutive entries into 3 different arms and counted only if a mouse entered into the 3 arms of maze (without revisiting the first arm at the third visit) <bold>(<xref ref-type="bibr" rid="c32">Hölter et al., 2015</xref>)</bold>.</p>
<p>Spatial memory was tested by placing the test mouse into the Y-maze with one arm of the maze closed off during training (Training session). This arm is designated as the novel arm. After 4 hours, during which the mouse is removed from the maze, the mouse is placed back into the maze with the blockage removed (Testing session). The number of entries into the novel arm was recorded for 10 min with the EthoVisionXT video-imaging system <bold>(<xref ref-type="bibr" rid="c43">Kraeuter et al., 2019</xref>)</bold>.</p>
</sec>
<sec id="s4e">
<title>Behavior: Novel object recognition (NOR)</title>
<p>NOR assay was used to explore cognitive performance in the long-term memory in a 50 × 50 cm opaque square arena. On Day 1, the mice were habituated to an open field arena for 5 min. On Day 2, the mice were exposed to 2 identical objects for a 5-min period. On Day 3, one of the objects was replaced with a new object, and the mice were let to explore the arena for 5 min. Each trial was recorded and the videos were automatically analyzed by EthoVision XT software (Noldus). The time spent with the familiar and novel objects was measured <bold>(<xref ref-type="bibr" rid="c67">Rungratanawanich et al., 2019</xref>)</bold>.</p>
</sec>
<sec id="s4f">
<title>Intranasal administration</title>
<p>According to the manufacturer’s instructions, 40 nmol of antagomiR-206-3p (sequence: 5’-CCACACACUUCCUUACAUUCCA -3’) or antagomiR-NC (the antagomiR negative control, its antisense chain sequence: 5’-UCUACUCUUUCUAGGAGGUUGUGA-3’) was dissolved in 1 mL of RNase-free water. A total of 24 mL of the solution (1 nmol per one mouse) was instilled with a pipette, alternately into the left and right nostrils (1 mL/time), with an interval of 3–5 min. The respiration of mice was not blocked, and other disorders were not observed; all mice in different groups survived. The same dosage and mode of administration were used for intranasal Cy5-antagomiR-206-3p administration (n = 3) to trace the distribution of antagomiR-206-3p after administration. We observed the overall and its sagittal section of the brain using ChemiDoc at 24 h after intranasal administration of Cy5-antagomiR-206-3p.</p>
</sec>
<sec id="s4g">
<title>Primary neuronal cell culture</title>
<p>As previous study reported <bold>(<xref ref-type="bibr" rid="c41">Kim et al., 2022</xref>)</bold>, pregnant C57BL/6 mice were obtained from a specific pathogen-free colony at Oriental Inc. (Seoul, Korea). Embryos were dissected from embryonic day 15.5 mice and prepared for culturing. The prefrontal cerebral cortices were dissected under sterile conditions, and the meninges were pulled off. The prefrontal cerebral cortices were then digested with 2.5% Trypsin-EDTA (Gibco BRL) in DMEM media for 15 min at 37 ◦C. After digestion, cells were dispersed through a pipette and filtered through a 70 μm nylon net filter. The cells were then centrifuged 5min at 500g; washed with Neurobasal medium containing B27 serumfree supplement (Thermo Scientific) and penicillin/streptomycin (Thermo Scientific). The cultured cells were incubated at 37 ◦C in a humidified atmosphere of 5% CO2.</p>
</sec>
<sec id="s4h">
<title>Image analysis</title>
<p>Primary cultured neuron and differentiated neuron was attached by a poly-d lysine–coated and laminin-coated confocal plate, respectively. Cells were fixed in 4% paraformaldehyde (5 min) and permeabilized with 0.1% Triton X-100 in PBS with 5% BSA (10 min). After blocking with 1% BSA in PBS (30 min), primary antibodies were incubated overnight at 4 ◦C and stained with secondary antibodies for 1 h. Coverslips were mounted with Fluoromount™ aqueous mounting medium. Samples were imaged with a confocal microscope (LSM 800 system). The microscopes were controlled by Zeiss black edition software. Secondary antibodies were labeled with Alexa Fluor 488, or 594.</p>
</sec>
<sec id="s4i">
<title>Dendritic spine distribution</title>
<p>The images of entire neurons were acquired at 20X magnification. For spine counts, the images were analyzed using a semiautomated analysis software (NeuronJ) publicly available at <ext-link ext-link-type="uri" xlink:href="https://imagescience.org/meijering/software/neuronj/manual/">https://imagescience.org/meijering/software/neuronj/manual/</ext-link> <bold>(<xref ref-type="bibr" rid="c86">Zhang et al., 2022</xref>)</bold>. Whole dendrite was subdivided into segments of 1 μm and number of spines across whole thickness were traced for length and breadth of each spine. Length and breadth ratio was used to determine the spine subtype as described earlier <bold>(B</bold>ą<bold>czy</bold>ń<bold>ska et al., 2021)</bold>. After the analysis for each class of spine, standard deviation and p-values are calculated using two-way Anova with Sidak’s multiple comparison method.</p>
</sec>
<sec id="s4j">
<title>Real-time qRT-PCR</title>
<p>The expression levels of mRNAs, miRNAs, and stemness and neuron-related genes were analyzed by real-time qRT-PCR, as previously described <bold>(<xref ref-type="bibr" rid="c70">Shin et al., 2022</xref>)</bold>. Aliquots of the master mix containing all of the reaction components with the primers were dispensed into a real-time PCR plate (Applied Biosystems, Foster City, CA, USA). All PCR reagents were from a SYBR Green core reagent kit (Applied Biosystems). The expressions of all genes were measured in triplicate in the reaction plate. The qRT-PCR was performed using the StepOne Real-Time PCR System (Applied Biosystems). It was performed by subjecting the samples at 95 ◦C for 15 s and at 60 ◦C for 1 min for 40 cycles followed by thermal denaturation. The expression of each gene relative to Gapdh mRNA was determined using the 2<sup>−ΔΔCT</sup> method.</p>
</sec>
<sec id="s4k">
<title>F/G-actin ratio</title>
<p>F/G-actin ratio was assessed as previously described <bold>(<xref ref-type="bibr" rid="c21">Festa et al., 2020</xref>)</bold>. Briefly, cells were lysed in cold lysis buffer [10 mM K<sub>2</sub>PO<sub>4</sub>, 100 mM NaF, 50 mM KCl, 2 mM MgCl<sub>2</sub>, 1 mM EGTA, 0.2 mM DTT, 0.5% Triton-X 100, 1 mM sucrose (pH 7.0)] and centrifuged at 15,000 × g for 30 min. Separation of F-actin and G-actin was achieved in that F-actin is insoluble (pellet) in this buffer, whereas G-actin is soluble (supernatant). The G-actin supernatant was transferred to a fresh tube and the F-actin pellet was resuspended in lysis buffer plus an equal volume of a second buffer [1.5 mM guanidine hydrochloride, 1 mM sodium acetate, 1 mM CaCl<sub>2</sub>, 1 mM ATP, 20 mM tris-HCl (pH 7.5)] and then incubated on ice for one hour with gentle mixing every 15 min to convert F-actin into soluble G-actin. Samples were centrifuged at 15,000 × g for 30 min and the supernatant (containing F-actin which was converted to G-actin) was transferred to a fresh tube. F-actin and G-actin samples were loaded with equal volumes and analyzed via Western blot.</p>
</sec>
<sec id="s4l">
<title>Western blot analysis</title>
<p>The assessment of protein levels was performed following previous study <bold>(<xref ref-type="bibr" rid="c39">Kang et al., 2023</xref>)</bold>. In brief, Whole cell lysates (WCL) were prepared using radioimmunoprecipitation assay (RIPA) lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1% Triton X-100, 25 mM NaF, 1 mM dithiothreitol (DTT), 20 mM EGTA, 1 mM Na<sub>3</sub>VO<sub>4</sub>, 0.3 mM phenylmethanesulfonyl fluoride (PMSF), and 5 U/mL aprotinin) and the protein concentrations in the lysates were determined using a BioRad protein assay kit (BioRad Laboratories, Hercules, CA). Protein samples were subjected to SDS-PAGE, transferred to a nitrocellulose membrane and then blocked with 5% bovine serum albumin in TBST for 1 h at RT. Next, membranes were probed with specific primary antibodies and peroxidase-conjugated secondary antibody (Santa Cruz Biotechnology). The samples were subsequently analyzed using an ECL detection system (Roche Applied Science, Indianapolis, IN). Detection and densitometric analysis were conducted using the iBright Western blot imaging systems (Thermofisher).</p>
</sec>
<sec id="s4lm">
<title>Statistical analysis</title>
<p>All numeric data are presented as the means ± standard deviation (SD) from at least three independent experiments. Experimental results were analyzed by one-way ANOVA for ranked data followed by Tukey’s honestly significant difference test. The Prism 9 software (GraphPad Software, SanDiego, CA) was used to conduct all statistical analyses. A p value &lt; 0.05 was considered to be statistically significant.</p>
</sec>
<sec id="s4n">
<title>Funding Sources</title>
<p>This research was supported by National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (2020M2D9A2094156) and the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (RS-2023-00207904).</p>
</sec>
<sec id="s4o">
<title>Availability of data and materials</title>
<p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p>
</sec>
<sec id="s4p">
<title>Ethics approval and consent to participate</title>
<p>The animal protocol used in this study was approved by the Pusan National University Institutional Animal Care and Use Committee (PNU-IACUC) for ethical procedures and scientific care (Approval Number PNU-2021-0055).</p>
</sec>
<sec id="s4q">
<title>Consent for publication</title>
<p>All co-authors have read and approved of its submission to this journal.</p>
</sec>
<sec id="s4r">
<title>Conflicts of interests</title>
<p>The authors declare no conflict of interest.</p>
</sec>
</sec>
<sec id="d1e1354" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material id="d1e1439">
<label>Supplementary Information</label>
<media xlink:href="supplements/547296_file08.pdf"/>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><string-name><surname>Arendt</surname>, <given-names>T.</given-names></string-name> (<year>2009</year>). <article-title>Synaptic degeneration in Alzheimer’s disease</article-title>. <source>Acta Neuropathol</source>, <volume>118</volume>(<issue>1</issue>), <fpage>167</fpage>–<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-009-0536-x</pub-id></mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><string-name><surname>Bączyńska</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Pels</surname>, <given-names>K. K.</given-names></string-name>, <string-name><surname>Basu</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Włodarczyk</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name><surname>Ruszczycki</surname>, <given-names>B.</given-names></string-name> (<year>2021</year>). <article-title>Quantification of Dendritic Spines Remodeling under Physiological Stimuli and in Pathological Conditions</article-title>. <source>Int J Mol Sci</source>, <volume>22</volume>(<fpage>8</fpage>). <pub-id pub-id-type="doi">10.3390/ijms22084053</pub-id></mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><string-name><surname>Baloyannis</surname>, <given-names>S. J.</given-names></string-name> (<year>2009</year>). <article-title>Dendritic pathology in Alzheimer’s disease</article-title>. <source>J Neurol Sci</source>, <volume>283</volume>(<issue>1-2</issue>), <fpage>153</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2009.02.370</pub-id></mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><string-name><surname>Bamburg</surname>, <given-names>J. R.</given-names></string-name>, <string-name><surname>Minamide</surname>, <given-names>L. S.</given-names></string-name>, <string-name><surname>Wiggan</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Tahtamouni</surname>, <given-names>L. H.</given-names></string-name>, &amp; <string-name><surname>Kuhn</surname>, <given-names>T. B.</given-names></string-name> (<year>2021</year>). <article-title>Cofilin and Actin Dynamics: Multiple Modes of Regulation and Their Impacts in Neuronal Development and Degeneration</article-title>. <source>Cells</source>, <volume>10</volume>(<fpage>10</fpage>). <pub-id pub-id-type="doi">10.3390/cells10102726</pub-id></mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><string-name><surname>Berry</surname>, <given-names>K. P.</given-names></string-name>, &amp; <string-name><surname>Nedivi</surname>, <given-names>E.</given-names></string-name> (<year>2017</year>). <article-title>Spine Dynamics: Are They All the Same?</article-title> <source>Neuron</source>, <volume>96</volume>(<issue>1</issue>), <fpage>43</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.08.008</pub-id></mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><string-name><surname>Bosch</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Castro</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Saneyoshi</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Matsuno</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Sur</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Hayashi</surname>, <given-names>Y.</given-names></string-name> (<year>2014</year>). <article-title>Structural and molecular remodeling of dendritic spine substructures during long-term potentiation</article-title>. <source>Neuron</source>, <volume>82</volume>(<issue>2</issue>), <fpage>444</fpage>–<lpage>459</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2014.03.021</pub-id></mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><string-name><surname>Brinkman</surname>, <given-names>T. M.</given-names></string-name>, <string-name><surname>Krasin</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Armstrong</surname>, <given-names>G. T.</given-names></string-name>, <string-name><surname>Ojha</surname>, <given-names>R. P.</given-names></string-name>, <string-name><surname>Sadighi</surname>, <given-names>Z. S.</given-names></string-name>, <string-name><surname>Gupta</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Kimberg</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Srivastava</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Merchant</surname>, <given-names>T. E.</given-names></string-name>, <string-name><surname>Gajjar</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Robison</surname>, <given-names>L. L.</given-names></string-name>, <string-name><surname>Hudson</surname>, <given-names>M. M.</given-names></string-name>, &amp; <string-name><surname>Krull</surname>, <given-names>K. R.</given-names></string-name> (<year>2016</year>). <article-title>Long-Term Neurocognitive Functioning and Social Attainment in Adult Survivors of Pediatric CNS Tumors: Results From the St Jude Lifetime Cohort Study</article-title>. <source>J Clin Oncol</source>, <volume>34</volume>(<issue>12</issue>), <fpage>1358</fpage>–<lpage>1367</lpage>. <pub-id pub-id-type="doi">10.1200/jco.2015.62.2589</pub-id></mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><string-name><surname>Brown</surname>, <given-names>P. D.</given-names></string-name>, <string-name><surname>Ahluwalia</surname>, <given-names>M. S.</given-names></string-name>, <string-name><surname>Khan</surname>, <given-names>O. H.</given-names></string-name>, <string-name><surname>Asher</surname>, <given-names>A. L.</given-names></string-name>, <string-name><surname>Wefel</surname>, <given-names>J. S.</given-names></string-name>, &amp; <string-name><surname>Gondi</surname>, <given-names>V.</given-names></string-name> (<year>2018</year>). <article-title>Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution?</article-title> <source>J Clin Oncol</source>, <volume>36</volume>(<issue>5</issue>), <fpage>483</fpage>–<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1200/jco.2017.75.9589</pub-id></mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><string-name><surname>Ceyzériat</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Zilli</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Fall</surname>, <given-names>A. B.</given-names></string-name>, <string-name><surname>Millet</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Koutsouvelis</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Dipasquale</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Frisoni</surname>, <given-names>G. B.</given-names></string-name>, <string-name><surname>Tournier</surname>, <given-names>B. B.</given-names></string-name>, &amp; <string-name><surname>Garibotto</surname>, <given-names>V.</given-names></string-name> (<year>2021</year>). <article-title>Treatment by low-dose brain radiation therapy improves memory performances without changes of the amyloid load in the TgF344-AD rat model</article-title>. <source>Neurobiol Aging</source>, <volume>103</volume>, <fpage>117</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2021.03.008</pub-id></mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><string-name><surname>Chen</surname>, <given-names>L. Y.</given-names></string-name>, <string-name><surname>Rex</surname>, <given-names>C. S.</given-names></string-name>, <string-name><surname>Casale</surname>, <given-names>M. S.</given-names></string-name>, <string-name><surname>Gall</surname>, <given-names>C. M.</given-names></string-name>, &amp; <string-name><surname>Lynch</surname>, <given-names>G.</given-names></string-name> (<year>2007</year>). <article-title>Changes in synaptic morphology accompany actin signaling during LTP</article-title>. <source>J Neurosci</source>, <volume>27</volume>(<issue>20</issue>), <fpage>5363</fpage>–<lpage>5372</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0164-07.2007</pub-id></mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><string-name><surname>Christensen</surname>, <given-names>A. J.</given-names></string-name>, <string-name><surname>Ott</surname>, <given-names>T.</given-names></string-name>, &amp; <string-name><surname>Kepecs</surname>, <given-names>A.</given-names></string-name> (<year>2022</year>). <article-title>Cognition and the single neuron: How cell types construct the dynamic computations of frontal cortex</article-title>. <source>Curr Opin Neurobiol</source>, <volume>77</volume>, <fpage>102630</fpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2022.102630</pub-id></mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><string-name><surname>Combeau</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Kreis</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Domenichini</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Amar</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Fossier</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Rousseau</surname>, <given-names>V.</given-names></string-name>, &amp; <string-name><surname>Barnier</surname>, <given-names>J. V.</given-names></string-name> (<year>2012</year>). <article-title>The p21-activated kinase PAK3 forms heterodimers with PAK1 in brain implementing trans-regulation of PAK3 activity</article-title>. <source>J Biol Chem</source>, <volume>287</volume>(<issue>36</issue>), <fpage>30084</fpage>–<lpage>30096</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.355073</pub-id></mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><string-name><surname>Conklin</surname>, <given-names>H. M.</given-names></string-name>, <string-name><surname>Krull</surname>, <given-names>K. R.</given-names></string-name>, <string-name><surname>Reddick</surname>, <given-names>W. E.</given-names></string-name>, <string-name><surname>Pei</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Cheng</surname>, <given-names>C.</given-names></string-name>, &amp; <string-name><surname>Pui</surname>, <given-names>C. H.</given-names></string-name> (<year>2012</year>). <article-title>Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia</article-title>. <source>J Natl Cancer Inst</source>, <volume>104</volume>(<issue>18</issue>), <fpage>1386</fpage>–<lpage>1395</lpage>. <pub-id pub-id-type="doi">10.1093/jnci/djs344</pub-id></mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><string-name><surname>Corrigan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Wilson</surname>, <given-names>S. S.</given-names></string-name>, &amp; <string-name><surname>Hampton</surname>, <given-names>J.</given-names></string-name> (<year>2015</year>). <article-title>Safety and efficacy of intranasally administered medications in the emergency department and prehospital settings</article-title>. <source>Am J Health Syst Pharm</source>, <volume>72</volume>(<issue>18</issue>), <fpage>1544</fpage>–<lpage>1554</lpage>. <pub-id pub-id-type="doi">10.2146/ajhp140630</pub-id></mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><string-name><surname>Counts</surname>, <given-names>S. E.</given-names></string-name>, <string-name><surname>Nadeem</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Lad</surname>, <given-names>S. P.</given-names></string-name>, <string-name><surname>Wuu</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name><surname>Mufson</surname>, <given-names>E. J.</given-names></string-name> (<year>2006</year>). <article-title>Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment</article-title>. <source>J Neuropathol Exp Neurol</source>, <volume>65</volume>(<issue>6</issue>), <fpage>592</fpage>–<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1097/00005072-200606000-00007</pub-id></mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><string-name><surname>Craft</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Raman</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Chow</surname>, <given-names>T. W.</given-names></string-name>, <string-name><surname>Rafii</surname>, <given-names>M. S.</given-names></string-name>, <string-name><surname>Sun</surname>, <given-names>C. K.</given-names></string-name>, <string-name><surname>Rissman</surname>, <given-names>R. A.</given-names></string-name>, <string-name><surname>Donohue</surname>, <given-names>M. C.</given-names></string-name>, <string-name><surname>Brewer</surname>, <given-names>J. B.</given-names></string-name>, <string-name><surname>Jenkins</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Harless</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Gessert</surname>, <given-names>D.</given-names></string-name>, &amp; <string-name><surname>Aisen</surname>, <given-names>P. S.</given-names></string-name> (<year>2020</year>). <article-title>Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial</article-title>. <source>JAMA Neurol</source>, <volume>77</volume>(<issue>9</issue>), <fpage>1099</fpage>–<lpage>1109</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2020.1840</pub-id></mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><string-name><surname>Delevich</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Okada</surname>, <given-names>N. J.</given-names></string-name>, <string-name><surname>Rahane</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Hall</surname>, <given-names>C. D.</given-names></string-name>, &amp; <string-name><surname>Wilbrecht</surname>, <given-names>L.</given-names></string-name> (<year>2020</year>). <article-title>Sex and Pubertal Status Influence Dendritic Spine Density on Frontal Corticostriatal Projection Neurons in Mice</article-title>. <source>Cereb Cortex</source>, <volume>30</volume>(<issue>6</issue>), <fpage>3543</fpage>–<lpage>3557</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhz325</pub-id></mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><string-name><surname>Ding</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>H. B.</given-names></string-name>, <string-name><surname>Qiu</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Wen</surname>, <given-names>X.</given-names></string-name>, &amp; <string-name><surname>Zhang</surname>, <given-names>L. Z.</given-names></string-name> (<year>2022</year>). <article-title>Cranial irradiation induces cognitive decline associated with altered dendritic spine morphology in the young rat hippocampus</article-title>. <source>Childs Nerv Syst</source>, <volume>38</volume>(<issue>10</issue>), <fpage>1867</fpage>–<lpage>1875</lpage>. <pub-id pub-id-type="doi">10.1007/s00381-022-05646-w</pub-id></mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><string-name><surname>Douglas</surname>, <given-names>K. M.</given-names></string-name>, <string-name><surname>Gallagher</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Robinson</surname>, <given-names>L. J.</given-names></string-name>, <string-name><surname>Carter</surname>, <given-names>J. D.</given-names></string-name>, <string-name><surname>McIntosh</surname>, <given-names>V. V.</given-names></string-name>, <string-name><surname>Frampton</surname>, <given-names>C. M.</given-names></string-name>, <string-name><surname>Watson</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Young</surname>, <given-names>A. H.</given-names></string-name>, <string-name><surname>Ferrier</surname>, <given-names>I. N.</given-names></string-name>, &amp; <string-name><surname>Porter</surname>, <given-names>R. J.</given-names></string-name> (<year>2018</year>). <article-title>Prevalence of cognitive impairment in major depression and bipolar disorder</article-title>. <source>Bipolar Disord</source>, <volume>20</volume>(<issue>3</issue>), <fpage>260</fpage>–<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1111/bdi.12602</pub-id></mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><string-name><surname>Edwards</surname>, <given-names>D. C.</given-names></string-name>, <string-name><surname>Sanders</surname>, <given-names>L. C.</given-names></string-name>, <string-name><surname>Bokoch</surname>, <given-names>G. M.</given-names></string-name>, &amp; <string-name><surname>Gill</surname>, <given-names>G. N.</given-names></string-name> (<year>1999</year>). <article-title>Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics</article-title>. <source>Nat Cell Biol</source>, <volume>1</volume>(<issue>5</issue>), <fpage>253</fpage>–<lpage>259</lpage>. <pub-id pub-id-type="doi">10.1038/12963</pub-id></mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><string-name><surname>Festa</surname>, <given-names>L. K.</given-names></string-name>, <string-name><surname>Irollo</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Platt</surname>, <given-names>B. J.</given-names></string-name>, <string-name><surname>Tian</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Floresco</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Meucci</surname>, <given-names>O.</given-names></string-name> (<year>2020</year>). <article-title>CXCL12-induced rescue of cortical dendritic spines and cognitive flexibility</article-title>. <source>Elife</source>, <volume>9</volume>. <pub-id pub-id-type="doi">10.7554/eLife.49717</pub-id></mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><string-name><surname>Fortuna</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Alves</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Serralheiro</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Sousa</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name><surname>Falcão</surname>, <given-names>A.</given-names></string-name> (<year>2014</year>). <article-title>Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules</article-title>. <source>Eur J Pharm Biopharm</source>, <volume>88</volume>(<issue>1</issue>), <fpage>8</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejpb.2014.03.004</pub-id></mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><string-name><surname>Fuchsova</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Alvarez Juliá</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Rizavi</surname>, <given-names>H. S.</given-names></string-name>, <string-name><surname>Frasch</surname>, <given-names>A. C.</given-names></string-name>, &amp; <string-name><surname>Pandey</surname>, <given-names>G. N.</given-names></string-name> (<year>2016</year>). <article-title>Expression of p21-activated kinases 1 and 3 is altered in the brain of subjects with depression</article-title>. <source>Neuroscience</source>, <volume>333</volume>, <fpage>331</fpage>–<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.07.037</pub-id></mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><string-name><surname>Furubayashi</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kamaguchi</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Kawaharada</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Masaoka</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Kataoka</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Yamashita</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Higashi</surname>, <given-names>Y.</given-names></string-name>, &amp; <string-name><surname>Sakane</surname>, <given-names>T.</given-names></string-name> (<year>2007</year>). <article-title>Evaluation of the contribution of the nasal cavity and gastrointestinal tract to drug absorption following nasal application to rats</article-title>. <source>Biol Pharm Bull</source>, <volume>30</volume>(<issue>3</issue>), <fpage>608</fpage>–<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.30.608</pub-id></mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><string-name><surname>Gebreegziabhere</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Habatmu</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Mihretu</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Cella</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Alem</surname>, <given-names>A.</given-names></string-name> (<year>2022</year>). <article-title>Cognitive impairment in people with schizophrenia: an umbrella review</article-title>. <source>Eur Arch Psychiatry Clin Neurosci</source>, <volume>272</volume>(<issue>7</issue>), <fpage>1139</fpage>–<lpage>1155</lpage>. <pub-id pub-id-type="doi">10.1007/s00406-022-01416-6</pub-id></mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><string-name><surname>Greene-Schloesser</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Moore</surname>, <given-names>E.</given-names></string-name>, &amp; <string-name><surname>Robbins</surname>, <given-names>M. E.</given-names></string-name> (<year>2013</year>). <article-title>Molecular pathways: radiation-induced cognitive impairment</article-title>. <source>Clin Cancer Res</source>, <volume>19</volume>(<issue>9</issue>), <fpage>2294</fpage>–<lpage>2300</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.Ccr-11-2903</pub-id></mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="web"><string-name><surname>Guan</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>D. W.</given-names></string-name>, <string-name><surname>Ji</surname>, <given-names>C. H.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>C. N.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Tang</surname>, <given-names>W. Q.</given-names></string-name>, <string-name><surname>Gu</surname>, <given-names>J. H.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>Y. M.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>J. F.</given-names></string-name>, &amp; <string-name><surname>Jiang</surname>, <given-names>B.</given-names></string-name> (<year>2021</year>). <article-title>Hippocampal miR-206-3p participates in the pathogenesis of depression via regulating the expression of BDNF</article-title>. <source>Pharmacol Res</source>, <volume>174</volume>, <fpage>105932</fpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2021.105932</pub-id></mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><string-name><surname>Harvey</surname>, <given-names>P. D.</given-names></string-name> (<year>2019</year>). <source>Domains of cognition and their assessment Dialogues Clin Neurosci</source>, <volume>21</volume>(<issue>3</issue>), <fpage>227</fpage>–<lpage>237</lpage>. <pub-id pub-id-type="doi">10.31887/DCNS.2019.21.3/pharvey</pub-id></mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><string-name><surname>Hering</surname>, <given-names>H.</given-names></string-name>, &amp; <string-name><surname>Sheng</surname>, <given-names>M.</given-names></string-name> (<year>2001</year>). <article-title>Dendritic spines: structure, dynamics and regulation</article-title>. <source>Nat Rev Neurosci</source>, <volume>2</volume>(<issue>12</issue>), <fpage>880</fpage>–<lpage>888</lpage>. <pub-id pub-id-type="doi">10.1038/35104061</pub-id></mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><string-name><surname>Hlushchenko</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Koskinen</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Hotulainen</surname>, <given-names>P.</given-names></string-name> (<year>2016</year>). <article-title>Dendritic spine actin dynamics in neuronal maturation and synaptic plasticity</article-title>. <source>Cytoskeleton (Hoboken</source>), <volume>73</volume>(<issue>9</issue>), <fpage>435</fpage>–<lpage>441</lpage>. <pub-id pub-id-type="doi">10.1002/cm.21280</pub-id></mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><string-name><surname>Hogeveen</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Medalla</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Ainsworth</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Galeazzi</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Hanlon</surname>, <given-names>C. A.</given-names></string-name>, <string-name><surname>Mansouri</surname>, <given-names>F. A.</given-names></string-name>, &amp; <string-name><surname>Costa</surname>, <given-names>V. D.</given-names></string-name> (<year>2022</year>). <article-title>What Does the Frontopolar Cortex Contribute to Goal-Directed Cognition and Action?</article-title> <source>J Neurosci</source>, <volume>42</volume>(<issue>45</issue>), <fpage>8508</fpage>–<lpage>8513</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.1143-22.2022</pub-id></mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><string-name><surname>Hölter</surname>, <given-names>S. M.</given-names></string-name>, <string-name><surname>Garrett</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Einicke</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Sperling</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Dirscherl</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Zimprich</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Fuchs</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Gailus-Durner</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Hrabě de Angelis</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Wurst</surname>, <given-names>W.</given-names></string-name> (<year>2015</year>). <article-title>Assessing Cognition in Mice</article-title>. <source>Curr Protoc Mouse Biol</source>, <volume>5</volume>(<issue>4</issue>), <fpage>331</fpage>–<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1002/9780470942390.mo150068</pub-id></mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><string-name><surname>Houillier</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Taillandier</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Dureau</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Lamy</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Laadhari</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Chinot</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Moluçon-Chabrot</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Soubeyran</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Gressin</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Choquet</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Damaj</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Thyss</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Abraham</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Delwail</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Gyan</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Sanhes</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Cornillon</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Garidi</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Delmer</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Soussain</surname>, <given-names>C.</given-names></string-name> (<year>2019</year>). <article-title>Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study</article-title>. <source>J Clin Oncol</source>, <volume>37</volume>(<issue>10</issue>), <fpage>823</fpage>-<lpage>833</lpage>. <pub-id pub-id-type="doi">10.1200/jco.18.00306</pub-id></mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><string-name><surname>Huang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Lafaille</surname>, <given-names>J. J.</given-names></string-name>, &amp; <string-name><surname>Yang</surname>, <given-names>G.</given-names></string-name> (<year>2021</year>). <article-title>Learning-dependent dendritic spine plasticity is impaired in spontaneous autoimmune encephalomyelitis</article-title>. <source>Dev Neurobiol</source>, <volume>81</volume>(<issue>5</issue>), <fpage>736</fpage>–<lpage>745</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22827</pub-id></mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><string-name><surname>Hussain</surname>, <given-names>N. K.</given-names></string-name>, <string-name><surname>Thomas</surname>, <given-names>G. M.</given-names></string-name>, <string-name><surname>Luo</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name><surname>Huganir</surname>, <given-names>R. L.</given-names></string-name> (<year>2015</year>). <article-title>Regulation of AMPA receptor subunit GluA1 surface expression by PAK3 phosphorylation</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>112</volume>(<issue>43</issue>), <fpage>E5883</fpage>–<lpage>5890</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1518382112</pub-id></mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><string-name><surname>Jauhar</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Johnstone</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>McKenna</surname>, <given-names>P. J.</given-names></string-name> (<year>2022</year>). <article-title>Schizophrenia</article-title>. <source>Lancet</source>, <volume>399</volume>(<issue>10323</issue>), <fpage>473</fpage>–<lpage>486</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(21)01730-x</pub-id></mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><string-name><surname>Jessen</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Amariglio</surname>, <given-names>R. E.</given-names></string-name>, <string-name><surname>Buckley</surname>, <given-names>R. F.</given-names></string-name>, <string-name><surname>van der Flier</surname>, <given-names>W. M.</given-names></string-name>, <string-name><surname>Han</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Molinuevo</surname>, <given-names>J. L.</given-names></string-name>, <string-name><surname>Rabin</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Rentz</surname>, <given-names>D. M.</given-names></string-name>, <string-name><surname>Rodriguez-Gomez</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Saykin</surname>, <given-names>A. J.</given-names></string-name>, <string-name><surname>Sikkes</surname>, <given-names>S. A. M.</given-names></string-name>, <string-name><surname>Smart</surname>, <given-names>C. M.</given-names></string-name>, <string-name><surname>Wolfsgruber</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Wagner</surname>, <given-names>M.</given-names></string-name> (<year>2020</year>). <article-title>The characterisation of subjective cognitive decline</article-title>. <source>Lancet Neurol</source>, <volume>19</volume>(<issue>3</issue>), <fpage>271</fpage>–<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1016/s1474-4422(19)30368-0</pub-id></mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><string-name><surname>Kandimalla</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Manczak</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Yin</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name><surname>Reddy</surname>, <given-names>P. H.</given-names></string-name> (<year>2018</year>). <article-title>Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer’s disease</article-title>. <source>Hum Mol Genet</source>, <volume>27</volume>(<issue>1</issue>), <fpage>30</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddx381</pub-id></mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><string-name><surname>Kang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Shin</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Kang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>J. S.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Youn</surname>, <given-names>H.</given-names></string-name>, &amp; <string-name><surname>Youn</surname>, <given-names>B.</given-names></string-name> (<year>2023</year>). <article-title>DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma</article-title>. <source>Cell Rep Med</source>, <volume>4</volume>(<issue>1</issue>), <fpage>100880</fpage>. <pub-id pub-id-type="doi">10.1016/j.xcrm.2022.100880</pub-id></mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><string-name><surname>Kang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Seo</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Son</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Park</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Jo</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Moon</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Youn</surname>, <given-names>H.</given-names></string-name>, &amp; <string-name><surname>Youn</surname>, <given-names>B.</given-names></string-name> (<year>2018</year>). <article-title>Radiation-induced overexpression of transthyretin inhibits retinol-mediated hippocampal neurogenesis</article-title>. <source>Sci Rep</source>, <volume>8</volume>(<issue>1</issue>), <fpage>8394</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-26762-1</pub-id></mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><string-name><surname>Kim</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Shin</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Kang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Jeon</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name><surname>Youn</surname>, <given-names>B.</given-names></string-name> (<year>2022</year>). <article-title>Baiap3 regulates depressive behaviors in mice via attenuating dense core vesicle trafficking in subsets of prefrontal cortex neurons</article-title>. <source>Neurobiol Stress</source>, <volume>16</volume>, <fpage>100423</fpage>. <pub-id pub-id-type="doi">10.1016/j.ynstr.2021.100423</pub-id></mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><string-name><surname>Kim</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Biag</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Fass</surname>, <given-names>D. M.</given-names></string-name>, <string-name><surname>Lewis</surname>, <given-names>M. C.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Fleishman</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Gangwar</surname>, <given-names>S. P.</given-names></string-name>, <string-name><surname>Machius</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Fromer</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Purcell</surname>, <given-names>S. M.</given-names></string-name>, <string-name><surname>McCarroll</surname>, <given-names>S. A.</given-names></string-name>, <string-name><surname>Rudenko</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Premont</surname>, <given-names>R. T.</given-names></string-name>, <string-name><surname>Scolnick</surname>, <given-names>E. M.</given-names></string-name>, &amp; <string-name><surname>Haggarty</surname>, <given-names>S. J.</given-names></string-name> (<year>2017</year>). <article-title>Functional analysis of rare variants found in schizophrenia implicates a critical role for GIT1-PAK3 signaling in neuroplasticity</article-title>. <source>Mol Psychiatry</source>, <volume>22</volume>(<issue>3</issue>), <fpage>417</fpage>–<lpage>429</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2016.98</pub-id></mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><string-name><surname>Kraeuter</surname>, <given-names>A. K.</given-names></string-name>, <string-name><surname>Guest</surname>, <given-names>P. C.</given-names></string-name>, &amp; <string-name><surname>Sarnyai</surname>, <given-names>Z.</given-names></string-name> (<year>2019</year>). <article-title>The Y-Maze for Assessment of Spatial Working and Reference Memory in Mice</article-title>. <source>Methods Mol Biol</source>, <volume>1916</volume>, <fpage>105</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-8994-2_10</pub-id></mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><string-name><surname>Krull</surname>, <given-names>K. R.</given-names></string-name>, <string-name><surname>Brinkman</surname>, <given-names>T. M.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Armstrong</surname>, <given-names>G. T.</given-names></string-name>, <string-name><surname>Ness</surname>, <given-names>K. K.</given-names></string-name>, <string-name><surname>Srivastava</surname>, <given-names>D. K.</given-names></string-name>, <string-name><surname>Gurney</surname>, <given-names>J. G.</given-names></string-name>, <string-name><surname>Kimberg</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Krasin</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Pui</surname>, <given-names>C. H.</given-names></string-name>, <string-name><surname>Robison</surname>, <given-names>L. L.</given-names></string-name>, &amp; <string-name><surname>Hudson</surname>, <given-names>M. M.</given-names></string-name> (<year>2013</year>). <article-title>Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study</article-title>. <source>J Clin Oncol</source>, <volume>31</volume>(<issue>35</issue>), <fpage>4407</fpage>–<lpage>4415</lpage>. <pub-id pub-id-type="doi">10.1200/jco.2012.48.2315</pub-id></mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><string-name><surname>Krull</surname>, <given-names>K. R.</given-names></string-name>, <string-name><surname>Hardy</surname>, <given-names>K. K.</given-names></string-name>, <string-name><surname>Kahalley</surname>, <given-names>L. S.</given-names></string-name>, <string-name><surname>Schuitema</surname>, <given-names>I.</given-names></string-name>, &amp; <string-name><surname>Kesler</surname>, <given-names>S. R.</given-names></string-name> (<year>2018</year>). <article-title>Neurocognitive Outcomes and Interventions in Long-Term Survivors of Childhood Cancer</article-title>. <source>J Clin Oncol</source>, <volume>36</volume>(<issue>21</issue>), <fpage>2181</fpage>–<lpage>2189</lpage>. <pub-id pub-id-type="doi">10.1200/jco.2017.76.4696</pub-id></mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><string-name><surname>Lamprecht</surname>, <given-names>R.</given-names></string-name> (<year>2021</year>). <article-title>Actin Cytoskeleton Role in the Maintenance of Neuronal Morphology and Long-Term Memory</article-title>. <source>Cells</source>, <volume>10</volume>(<fpage>7</fpage>). <pub-id pub-id-type="doi">10.3390/cells10071795</pub-id></mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><string-name><surname>Lauterborn</surname>, <given-names>J. C.</given-names></string-name>, <string-name><surname>Cox</surname>, <given-names>C. D.</given-names></string-name>, <string-name><surname>Chan</surname>, <given-names>S. W.</given-names></string-name>, <string-name><surname>Vanderklish</surname>, <given-names>P. W.</given-names></string-name>, <string-name><surname>Lynch</surname>, <given-names>G.</given-names></string-name>, &amp; <string-name><surname>Gall</surname>, <given-names>C. M.</given-names></string-name> (<year>2020</year>). <article-title>Synaptic actin stabilization protein loss in Down syndrome and Alzheimer disease</article-title>. <source>Brain Pathol</source>, <volume>30</volume>(<issue>2</issue>), <fpage>319</fpage>–<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1111/bpa.12779</pub-id></mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><string-name><surname>Lawson</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Snyder</surname>, <given-names>W.</given-names></string-name>, &amp; <string-name><surname>Peeples</surname>, <given-names>E. S.</given-names></string-name> (<year>2022</year>). <article-title>Intranasal Administration of Extracellular Vesicles Mitigates Apoptosis in a Mouse Model of Neonatal Hypoxic-Ischemic Brain Injury</article-title>. <source>Neonatology</source>, <volume>119</volume>(<issue>3</issue>), <fpage>345</fpage>–<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1159/000522644</pub-id></mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><string-name><surname>Lei</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Omotade</surname>, <given-names>O. F.</given-names></string-name>, <string-name><surname>Myers</surname>, <given-names>K. R.</given-names></string-name>, &amp; <string-name><surname>Zheng</surname>, <given-names>J. Q.</given-names></string-name> (<year>2016</year>). <article-title>Actin cytoskeleton in dendritic spine development and plasticity</article-title>. <source>Curr Opin Neurobiol</source>, <volume>39</volume>, <fpage>86</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2016.04.010</pub-id></mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><string-name><surname>Liu</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>K.</given-names></string-name>, &amp; <string-name><surname>Dong</surname>, <given-names>Z.</given-names></string-name> (<year>2021</year>). <article-title>The Role of p21-Activated Kinases in Cancer and Beyond: Where Are We Heading?</article-title> <source>Front Cell Dev Biol</source>, <volume>9</volume>, <fpage>641381</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2021.641381</pub-id></mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><string-name><surname>Mai</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Fan</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Cai</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Tang</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Zou</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Hong</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Wan</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>B.</given-names></string-name>, &amp; <string-name><surname>Cui</surname>, <given-names>L.</given-names></string-name> (<year>2019</year>). <article-title>Intranasal Administration of miR-146a Agomir Rescued the Pathological Process and Cognitive Impairment in an AD Mouse Model</article-title>. <source>Mol Ther Nucleic Acids</source>, <volume>18</volume>, <fpage>681</fpage>–<lpage>695</lpage>. <pub-id pub-id-type="doi">10.1016/j.omtn.2019.10.002</pub-id></mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><string-name><surname>Makale</surname>, <given-names>M. T.</given-names></string-name>, <string-name><surname>McDonald</surname>, <given-names>C. R.</given-names></string-name>, <string-name><surname>Hattangadi-Gluth</surname>, <given-names>J. A.</given-names></string-name>, &amp; <string-name><surname>Kesari</surname>, <given-names>S.</given-names></string-name> (<year>2017</year>). <article-title>Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours</article-title>. <source>Nat Rev Neurol</source>, <volume>13</volume>(<issue>1</issue>), <fpage>52</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2016.185</pub-id></mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><string-name><surname>Meng</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Meng</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Hanna</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Janus</surname>, <given-names>C.</given-names></string-name>, &amp; <string-name><surname>Jia</surname>, <given-names>Z.</given-names></string-name> (<year>2005</year>). <article-title>Abnormal long-lasting synaptic plasticity and cognition in mice lacking the mental retardation gene Pak3</article-title>. <source>J Neurosci</source>, <volume>25</volume>(<issue>28</issue>), <fpage>6641</fpage>–<lpage>6650</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0028-05.2005</pub-id></mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><string-name><surname>Mistry</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Stolnik</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Illum</surname>, <given-names>L.</given-names></string-name> (<year>2009</year>). <article-title>Nanoparticles for direct nose-to-brain delivery of drugs</article-title>. <source>Int J Pharm</source>, <volume>379</volume>(<issue>1</issue>), <fpage>146</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpharm.2009.06.019</pub-id></mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><string-name><surname>Molli</surname>, <given-names>P. R.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>D. Q.</given-names></string-name>, <string-name><surname>Murray</surname>, <given-names>B. W.</given-names></string-name>, <string-name><surname>Rayala</surname>, <given-names>S. K.</given-names></string-name>, &amp; <string-name><surname>Kumar</surname>, <given-names>R.</given-names></string-name> (<year>2009</year>). <article-title>PAK signaling in oncogenesis</article-title>. <source>Oncogene</source>, <volume>28</volume>(<issue>28</issue>), <fpage>2545</fpage>–<lpage>2555</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2009.119</pub-id></mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><string-name><surname>Morrow</surname>, <given-names>E. M.</given-names></string-name>, <string-name><surname>Kane</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Goff</surname>, <given-names>D. C.</given-names></string-name>, &amp; <string-name><surname>Walsh</surname>, <given-names>C. A.</given-names></string-name> (<year>2008</year>). <article-title>Sequence analysis of P21-activated kinase 3 (PAK3) in chronic schizophrenia with cognitive impairment</article-title>. <source>Schizophr Res</source>, <volume>106</volume>(<issue>2-3</issue>), <fpage>265</fpage>–<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2008.08.021</pub-id></mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><string-name><surname>Nakahata</surname>, <given-names>Y.</given-names></string-name>, &amp; <string-name><surname>Yasuda</surname>, <given-names>R.</given-names></string-name> (<year>2018</year>). <article-title>Plasticity of Spine Structure: Local Signaling, Translation and Cytoskeletal Reorganization</article-title>. <source>Front Synaptic Neurosci</source>, <volume>10</volume>, <fpage>29</fpage>. <pub-id pub-id-type="doi">10.3389/fnsyn.2018.00029</pub-id></mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><string-name><surname>Owonikoko</surname>, <given-names>T. K.</given-names></string-name>, <string-name><surname>Arbiser</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Zelnak</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Shu</surname>, <given-names>H. K.</given-names></string-name>, <string-name><surname>Shim</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Robin</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Kalkanis</surname>, <given-names>S. N.</given-names></string-name>, <string-name><surname>Whitsett</surname>, <given-names>T. G.</given-names></string-name>, <string-name><surname>Salhia</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Tran</surname>, <given-names>N. L.</given-names></string-name>, <string-name><surname>Ryken</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Moore</surname>, <given-names>M. K.</given-names></string-name>, <string-name><surname>Egan</surname>, <given-names>K. M.</given-names></string-name>, &amp; <string-name><surname>Olson</surname>, <given-names>J. J.</given-names></string-name> (<year>2014</year>). <article-title>Current approaches to the treatment of metastatic brain tumours</article-title>. <source>Nat Rev Clin Oncol</source>, <volume>11</volume>(<issue>4</issue>), <fpage>203</fpage>–<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1038/nrclinonc.2014.25</pub-id></mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><string-name><surname>Pazzaglia</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Briganti</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Mancuso</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Saran</surname>, <given-names>A.</given-names></string-name> (<year>2020</year>). <article-title>Neurocognitive Decline Following Radiotherapy: Mechanisms and Therapeutic Implications</article-title>. <source>Cancers (Basel</source>), <volume>12</volume>(<fpage>1</fpage>). <pub-id pub-id-type="doi">10.3390/cancers12010146</pub-id></mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><string-name><surname>Price</surname>, <given-names>R. B.</given-names></string-name>, &amp; <string-name><surname>Duman</surname>, <given-names>R.</given-names></string-name> (<year>2020</year>). <article-title>Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model</article-title>. <source>Mol Psychiatry</source>, <volume>25</volume>(<issue>3</issue>), <fpage>530</fpage>–<lpage>543</lpage>. <pub-id pub-id-type="doi">10.1038/s41380-019-0615-x</pub-id></mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><string-name><surname>Quintana</surname>, <given-names>D. S.</given-names></string-name>, <string-name><surname>Guastella</surname>, <given-names>A. J.</given-names></string-name>, <string-name><surname>Westlye</surname>, <given-names>L. T.</given-names></string-name>, &amp; <string-name><surname>Andreassen</surname>, <given-names>O. A.</given-names></string-name> (<year>2016</year>). <article-title>The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders</article-title>. <source>Mol Psychiatry</source>, <volume>21</volume>(<issue>1</issue>), <fpage>29</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2015.166</pub-id></mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><string-name><surname>Raber</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Rola</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>LeFevour</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Morhardt</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Curley</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Mizumatsu</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>VandenBerg</surname>, <given-names>S. R.</given-names></string-name>, &amp; <string-name><surname>Fike</surname>, <given-names>J. R.</given-names></string-name> (<year>2004</year>). <article-title>Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis</article-title>. <source>Radiat Res</source>, <volume>162</volume>(<issue>1</issue>), <fpage>39</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1667/rr3206</pub-id></mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><string-name><surname>Rane</surname>, <given-names>C. K.</given-names></string-name>, &amp; <string-name><surname>Minden</surname>, <given-names>A.</given-names></string-name> (<year>2014</year>). <article-title>P21 activated kinases: structure, regulation, and functions</article-title>. <source>Small GTPases</source>, <volume>5</volume>. <pub-id pub-id-type="doi">10.4161/sgtp.28003</pub-id></mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><string-name><surname>Rapp</surname>, <given-names>S. R.</given-names></string-name>, <string-name><surname>Case</surname>, <given-names>L. D.</given-names></string-name>, <string-name><surname>Peiffer</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Naughton</surname>, <given-names>M. M.</given-names></string-name>, <string-name><surname>Chan</surname>, <given-names>M. D.</given-names></string-name>, <string-name><surname>Stieber</surname>, <given-names>V. W.</given-names></string-name>, <string-name><surname>Moore</surname>, <given-names>D. F.</given-names>, <suffix>Jr.</suffix></string-name>, <string-name><surname>Falchuk</surname>, <given-names>S. C.</given-names></string-name>, <string-name><surname>Piephoff</surname>, <given-names>J. V.</given-names></string-name>, <string-name><surname>Edenfield</surname>, <given-names>W. J.</given-names></string-name>, <string-name><surname>Giguere</surname>, <given-names>J. K.</given-names></string-name>, <string-name><surname>Loghin</surname>, <given-names>M. E.</given-names></string-name>, &amp; <string-name><surname>Shaw</surname>, <given-names>E. G.</given-names></string-name> (<year>2015</year>). <article-title>Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial</article-title>. <source>J Clin Oncol</source>, <volume>33</volume>(<issue>15</issue>), <fpage>1653</fpage>–<lpage>1659</lpage>. <pub-id pub-id-type="doi">10.1200/jco.2014.58.4508</pub-id></mixed-citation></ref>
<ref id="c65"><mixed-citation publication-type="journal"><string-name><surname>Rex</surname>, <given-names>C. S.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>L. Y.</given-names></string-name>, <string-name><surname>Sharma</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Babayan</surname>, <given-names>A. H.</given-names></string-name>, <string-name><surname>Gall</surname>, <given-names>C. M.</given-names></string-name>, &amp; <string-name><surname>Lynch</surname>, <given-names>G.</given-names></string-name> (<year>2009</year>). <article-title>Different Rho GTPase-dependent signaling pathways initiate sequential steps in the consolidation of long-term potentiation</article-title>. <source>J Cell Biol</source>, <volume>186</volume>(<issue>1</issue>), <fpage>85</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200901084</pub-id></mixed-citation></ref>
<ref id="c66"><mixed-citation publication-type="journal"><string-name><surname>Rosi</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Andres-Mach</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Fishman</surname>, <given-names>K. M.</given-names></string-name>, <string-name><surname>Levy</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Ferguson</surname>, <given-names>R. A.</given-names></string-name>, &amp; <string-name><surname>Fike</surname>, <given-names>J. R.</given-names></string-name> (<year>2008</year>). <article-title>Cranial irradiation alters the behaviorally induced immediate-early gene arc (activity-regulated cytoskeleton-associated protein)</article-title>. <source>Cancer Res</source>, <volume>68</volume>(<issue>23</issue>), <fpage>9763</fpage>–<lpage>9770</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.Can-08-1861</pub-id></mixed-citation></ref>
<ref id="c67"><mixed-citation publication-type="journal"><string-name><surname>Rungratanawanich</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Cenini</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Mastinu</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Sylvester</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Wilkening</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Abate</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Bonini</surname>, <given-names>S. A.</given-names></string-name>, <string-name><surname>Aria</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Marziano</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Maccarinelli</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Memo</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Voos</surname>, <given-names>W.</given-names></string-name>, &amp; <string-name><surname>Uberti</surname>, <given-names>D.</given-names></string-name> (<year>2019</year>). <article-title>γ-Oryzanol Improves Cognitive Function and Modulates Hippocampal Proteome in Mice</article-title>. <source>Nutrients</source>, <volume>11</volume>(<fpage>4</fpage>). <pub-id pub-id-type="doi">10.3390/nu11040753</pub-id></mixed-citation></ref>
<ref id="c68"><mixed-citation publication-type="journal"><string-name><surname>Sakimoto</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Oo</surname>, <given-names>P. M.</given-names></string-name>, <string-name><surname>Goshima</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kanehisa</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Tsukada</surname>, <given-names>Y.</given-names></string-name>, &amp; <string-name><surname>Mitsushima</surname>, <given-names>D.</given-names></string-name> (<year>2021</year>). <article-title>Significance of GABA(A) Receptor for Cognitive Function and Hippocampal Pathology</article-title>. <source>Int J Mol Sci</source>, <volume>22</volume>(<fpage>22</fpage>). <pub-id pub-id-type="doi">10.3390/ijms222212456</pub-id></mixed-citation></ref>
<ref id="c69"><mixed-citation publication-type="journal"><string-name><surname>Shah</surname>, <given-names>S. S.</given-names></string-name>, <string-name><surname>Dellarole</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Peterson</surname>, <given-names>E. C.</given-names></string-name>, <string-name><surname>Bregy</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Komotar</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Harvey</surname>, <given-names>P. D.</given-names></string-name>, &amp; <string-name><surname>Elhammady</surname>, <given-names>M. S.</given-names></string-name> (<year>2015</year>). <article-title>Long-term psychiatric outcomes in pediatric brain tumor survivors</article-title>. <source>Childs Nerv Syst</source>, <volume>31</volume>(<issue>5</issue>), <fpage>653</fpage>–<lpage>663</lpage>. <pub-id pub-id-type="doi">10.1007/s00381-015-2669-7</pub-id></mixed-citation></ref>
<ref id="c70"><mixed-citation publication-type="journal"><string-name><surname>Shin</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Kang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Jeon</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Seong</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Youn</surname>, <given-names>H.</given-names></string-name>, &amp; <string-name><surname>Youn</surname>, <given-names>B.</given-names></string-name> (<year>2022</year>). <article-title>Exosomal Plasminogen Activator Inhibitor-1 Induces Ionizing Radiation-Adaptive Glioblastoma Cachexia</article-title>. <source>Cells</source>, <volume>11</volume>(<fpage>19</fpage>). <pub-id pub-id-type="doi">10.3390/cells11193102</pub-id></mixed-citation></ref>
<ref id="c71"><mixed-citation publication-type="journal"><string-name><surname>Shin</surname>, <given-names>E. Y.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>C. S.</given-names></string-name>, <string-name><surname>Cho</surname>, <given-names>T. G.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>Y. G.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Juhnn</surname>, <given-names>Y. S.</given-names></string-name>, <string-name><surname>Park</surname>, <given-names>S. C.</given-names></string-name>, <string-name><surname>Manser</surname>, <given-names>E.</given-names></string-name>, &amp; <string-name><surname>Kim</surname>, <given-names>E. G.</given-names></string-name> (<year>2006</year>). <article-title>betaPak-interacting exchange factor-mediated Rac1 activation requires smgGDS guanine nucleotide exchange factor in basic fibroblast growth factor-induced neurite outgrowth</article-title>. <source>J Biol Chem</source>, <volume>281</volume>(<issue>47</issue>), <fpage>35954</fpage>–<lpage>35964</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M602399200</pub-id></mixed-citation></ref>
<ref id="c72"><mixed-citation publication-type="journal"><string-name><surname>Slotman</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Faivre-Finn</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Kramer</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Rankin</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Snee</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Hatton</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Postmus</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Collette</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Musat</surname>, <given-names>E.</given-names></string-name>, &amp; <string-name><surname>Senan</surname>, <given-names>S.</given-names></string-name> (<year>2007</year>). <article-title>Prophylactic cranial irradiation in extensive small-cell lung cancer</article-title>. <source>N Engl J Med</source>, <volume>357</volume>(<issue>7</issue>), <fpage>664</fpage>–<lpage>672</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa071780</pub-id></mixed-citation></ref>
<ref id="c73"><mixed-citation publication-type="journal"><string-name><surname>Smith</surname>, <given-names>K. R.</given-names></string-name>, <string-name><surname>Davenport</surname>, <given-names>E. C.</given-names></string-name>, <string-name><surname>Wei</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Pathania</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Vaccaro</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Yan</surname>, <given-names>Z.</given-names></string-name>, &amp; <string-name><surname>Kittler</surname>, <given-names>J. T.</given-names></string-name> (<year>2014</year>). <article-title>GIT1 and βPIX are essential for GABA(A) receptor synaptic stability and inhibitory neurotransmission</article-title>. <source>Cell Rep</source>, <volume>9</volume>(<issue>1</issue>), <fpage>298</fpage>–<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2014.08.061</pub-id></mixed-citation></ref>
<ref id="c74"><mixed-citation publication-type="journal"><string-name><surname>Suwinski</surname>, <given-names>R.</given-names></string-name> (<year>2021</year>). <article-title>Prophylactic cranial irradiation in SCLC</article-title>. <source>Transl Lung Cancer Res</source>, <volume>10</volume>(<issue>4</issue>), <fpage>2071</fpage>–<lpage>2078</lpage>. <pub-id pub-id-type="doi">10.21037/tlcr-2020-rtm-05</pub-id></mixed-citation></ref>
<ref id="c75"><mixed-citation publication-type="journal"><string-name><surname>Szatmari</surname>, <given-names>E. M.</given-names></string-name>, <string-name><surname>Moran</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Cohen</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Jacob</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Parra-Bueno</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Kamasawa</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Guerrero-Given</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Klein</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Stackman</surname>, <given-names>R.</given-names>, <suffix>Jr.</suffix></string-name>, &amp; <string-name><surname>Yasuda</surname>, <given-names>R.</given-names></string-name> (<year>2021</year>). <article-title>ADAP1/Centaurin-α1 Negatively Regulates Dendritic Spine Function and Memory Formation in the Hippocampus</article-title>. <source>eNeuro</source>, <volume>8</volume>(<fpage>1</fpage>). <pub-id pub-id-type="doi">10.1523/eneuro.0111-20.2020</pub-id></mixed-citation></ref>
<ref id="c76"><mixed-citation publication-type="journal"><string-name><surname>Thévenot</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Moreau</surname>, <given-names>A. W.</given-names></string-name>, <string-name><surname>Rousseau</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Combeau</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Domenichini</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Jacquet</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Goupille</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Amar</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kreis</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Fossier</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name><surname>Barnier</surname>, <given-names>J. V.</given-names></string-name> (<year>2011</year>). <article-title>p21-Activated kinase 3 (PAK3) protein regulates synaptic transmission through its interaction with the Nck2/Grb4 protein adaptor</article-title>. <source>J Biol Chem</source>, <volume>286</volume>(<issue>46</issue>), <fpage>40044</fpage>–<lpage>40059</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.262246</pub-id></mixed-citation></ref>
<ref id="c77"><mixed-citation publication-type="journal"><string-name><surname>Tucker</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Tucker</surname>, <given-names>L.</given-names></string-name>, &amp; <string-name><surname>Brown</surname>, <given-names>K.</given-names></string-name> (<year>2018</year>). <article-title>The Intranasal Route as an Alternative Method of Medication Administration</article-title>. <source>Crit Care Nurse</source>, <volume>38</volume>(<issue>5</issue>), <fpage>26</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.4037/ccn2018836</pub-id></mixed-citation></ref>
<ref id="c78"><mixed-citation publication-type="journal"><string-name><surname>Wegner</surname>, <given-names>R. E.</given-names></string-name>, <string-name><surname>Abel</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Horne</surname>, <given-names>Z. D.</given-names></string-name>, <string-name><surname>Hasan</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Verma</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Ranjan</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Williamson</surname>, <given-names>R. W.</given-names></string-name>, &amp; <string-name><surname>Karlovits</surname>, <given-names>S. M.</given-names></string-name> (<year>2019</year>). <article-title>National trends in radiation dose escalation for glioblastoma</article-title>. <source>Radiat Oncol J</source>, <volume>37</volume>(<issue>1</issue>), <fpage>13</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.3857/roj.2019.00017</pub-id></mixed-citation></ref>
<ref id="c79"><mixed-citation publication-type="journal"><string-name><surname>Wen</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Dong</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Y.</given-names></string-name>, &amp; <string-name><surname>Li</surname>, <given-names>K.</given-names></string-name> (<year>2022</year>). <article-title>Depression and Cognitive Impairment: Current Understanding of Its Neurobiology and Diagnosis</article-title>. <source>Neuropsychiatr Dis Treat</source>, <volume>18</volume>, <fpage>2783</fpage>–<lpage>2794</lpage>. <pub-id pub-id-type="doi">10.2147/ndt.S383093</pub-id></mixed-citation></ref>
<ref id="c80"><mixed-citation publication-type="journal"><string-name><surname>Wilson</surname>, <given-names>G. D.</given-names></string-name>, <string-name><surname>Wilson</surname>, <given-names>T. G.</given-names></string-name>, <string-name><surname>Hanna</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Fontanesi</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Kulchycki</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Buelow</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Pruetz</surname>, <given-names>B. L.</given-names></string-name>, <string-name><surname>Michael</surname>, <given-names>D. B.</given-names></string-name>, <string-name><surname>Chinnaiyan</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Maddens</surname>, <given-names>M. E.</given-names></string-name>, <string-name><surname>Martinez</surname>, <given-names>A. A.</given-names></string-name>, &amp; <string-name><surname>Fontanesi</surname>, <given-names>J.</given-names></string-name> (<year>2020</year>). <article-title>Low Dose Brain Irradiation Reduces Amyloid-β and Tau in 3xTg-AD Mice</article-title>. <source>J Alzheimers Dis</source>, <volume>75</volume>(<issue>1</issue>), <fpage>15</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.3233/jad-200030</pub-id></mixed-citation></ref>
<ref id="c81"><mixed-citation publication-type="journal"><string-name><surname>Wu</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Jiang</surname>, <given-names>X.</given-names></string-name> (<year>2022</year>). <article-title>p21-Activated kinases as promising therapeutic targets in hematological malignancies</article-title>. <source>Leukemia</source>, <volume>36</volume>(<issue>2</issue>), <fpage>315</fpage>–<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1038/s41375-021-01451-7</pub-id></mixed-citation></ref>
<ref id="c82"><mixed-citation publication-type="journal"><string-name><surname>Xue</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Zeng</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Yan</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Q.</given-names></string-name>, &amp; <string-name><surname>Jia</surname>, <given-names>X.</given-names></string-name> (<year>2022</year>). <article-title>Prophylactic Cranial Irradiation for Extensive-Stage Small-Cell Lung Cancer: A Controversial Area</article-title>. <source>Front Oncol</source>, <volume>12</volume>, <fpage>772282</fpage>. <pub-id pub-id-type="doi">10.3389/fonc.2022.772282</pub-id></mixed-citation></ref>
<ref id="c83"><mixed-citation publication-type="journal"><string-name><surname>Yang</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Zimmermann</surname>, <given-names>H. R.</given-names></string-name>, &amp; <string-name><surname>Ma</surname>, <given-names>T.</given-names></string-name> (<year>2021</year>). <article-title>Brain-specific suppression of AMPKα2 isoform impairs cognition and hippocampal LTP by PERK-mediated eIF2α phosphorylation</article-title>. <source>Mol Psychiatry</source>, <volume>26</volume>(<issue>6</issue>), <fpage>1880</fpage>–<lpage>1897</lpage>. <pub-id pub-id-type="doi">10.1038/s41380-020-0739-z</pub-id></mixed-citation></ref>
<ref id="c84"><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Lam</surname>, <given-names>T. T.</given-names></string-name>, <string-name><surname>Weng</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Bronk</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Ma</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Duman</surname>, <given-names>J. G.</given-names></string-name>, <string-name><surname>Dougherty</surname>, <given-names>P. M.</given-names></string-name>, &amp; <string-name><surname>Grosshans</surname>, <given-names>D. R.</given-names></string-name> (<year>2018</year>). <article-title>Radiation induces age-dependent deficits in cortical synaptic plasticity</article-title>. <source>Neuro Oncol</source>, <volume>20</volume>(<issue>9</issue>), <fpage>1207</fpage>–<lpage>1214</lpage>. <pub-id pub-id-type="doi">10.1093/neuonc/noy052</pub-id></mixed-citation></ref>
<ref id="c85"><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Webb</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Asmussen</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Niu</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Horwitz</surname>, <given-names>A. F.</given-names></string-name> (<year>2005</year>). <article-title>A GIT1/PIX/Rac/PAK signaling module regulates spine morphogenesis and synapse formation through MLC</article-title>. <source>J Neurosci</source>, <volume>25</volume>(<issue>13</issue>), <fpage>3379</fpage>–<lpage>3388</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.3553-04.2005</pub-id></mixed-citation></ref>
<ref id="c86"><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>W.</given-names></string-name>, &amp; <string-name><surname>Huang</surname>, <given-names>X.</given-names></string-name> (<year>2022</year>). <article-title>Semiautomated and Automated Quantitative Analysis of Corneal Sub-Basal Nerves in Patients With DED With Ocular Pain Using IVCM</article-title>. <source>Front Med (Lausanne</source>), <volume>9</volume>, <fpage>831307</fpage>. <pub-id pub-id-type="doi">10.3389/fmed.2022.831307</pub-id></mixed-citation></ref>
</ref-list>
<sec id="s5">
<title>Supplementary Information for</title>
<sec id="s5b">
<title>Supplemental Tables</title>
<table-wrap id="tbls1" orientation="portrait" position="float">
<label>S1 Table.</label>
<caption><title>Primers for determining levels of gene expression</title></caption>
<graphic xlink:href="547296v1_tbls1.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
</sec>
<sec id="s5a">
<title>Supplemental Figures</title>
<fig id="figs1" position="float" orientation="portrait" fig-type="figure">
<label>S1 Fig.</label>
<caption><title>Cranial radiation affects depressive-like behavior (related to Figure 1)</title>
<p><bold>(A)</bold> The representative heatmaps of open field test after IR. (<bold>B)</bold> The result of open field test after IR. Statistical analysis was performed with Student’s t test. ns, non-significant; ***<italic>p</italic> &lt; 0.001.</p></caption>
<graphic xlink:href="547296v1_figs1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs2" position="float" orientation="portrait" fig-type="figure">
<label>S2 Fig.</label>
<caption><title>PAK3 is related to synapse organization and dendritic spine development in frontal cortex and hippocampus (related to Figure 2)</title>
<p><bold>(A)</bold> The localization of PAK3 in mouse and three human brain from Allen brain map (<ext-link ext-link-type="uri" xlink:href="https://portal.brain-map.org/">https://portal.brain-map.org/</ext-link>). (<bold>B)</bold> The changes of PAK3 mRNA level after IR in frontal cortex and hippocampus. (<bold>C)</bold> Left: the protein levels of phosphorylated LIMK1, LIMK1, phosphorylated cofilin, and cofilin after IR in frontal cortex and hippocampus. Right: each western blot bands are quantified by ImageJ. Statistical analysis was performed with Student’s t test. **<italic>p &lt; 0.01</italic>; ***<italic>p</italic> &lt; 0.001; ****<italic>p</italic> &lt; 0.0001.</p></caption>
<graphic xlink:href="547296v1_figs2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs3" position="float" orientation="portrait" fig-type="figure">
<label>S3 Fig.</label>
<caption><title>OP18 and TBCB signaling are not affected by IR (related to Figure 2)</title>
<p><bold>(A)</bold> The protein levels of phosphorylated OP18, OP18, TBCB after IR in cortical neuron. (<bold>B)</bold> The protein levels of phosphorylated OP18, OP18, TBCB after IR in frontal cortex and hippocampus.</p></caption>
<graphic xlink:href="547296v1_figs3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs4" position="float" orientation="portrait" fig-type="figure">
<label>S4 Fig.</label>
<caption><title>Neural progenitor cell is differentiated to human neuron (related to Figure 4)</title>
<p><bold>(A)</bold> The mRNA levels of SOX2, Nestin, and PAX6 in neural progenitor cell and differentiated neuron. (<bold>B)</bold> The protein levels of PSD95, NeuN, SOX2, and GAPDH. Statistical analysis was performed with Student’s t test. ***<italic>p</italic> &lt; 0.001; ****<italic>p</italic> &lt; 0.0001.</p></caption>
<graphic xlink:href="547296v1_figs4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs5" position="float" orientation="portrait" fig-type="figure">
<label>S5 Fig.</label>
<caption><title>AntagomiR-206-3p attenuates depressive-like behavior (related to Figure 6)</title>
<p><bold>(A)</bold> The representative heatmaps of open field test after IR or IR with antagomiR-206-3p. (<bold>B)</bold> The result of open field test after IR or IR with antagomiR-206-3p. Statistical analysis was performed with one-way ANOVA plus a Tukey’s multiple comparisons test. ns, non-significant; ****<italic>p</italic> &lt; 0.0001.</p></caption>
<graphic xlink:href="547296v1_figs5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs6" position="float" orientation="portrait" fig-type="figure">
<label>S6 Fig.</label>
<caption><title>Summary of alterations to PAK3 signaling in dendritic spine upon IR exposure.</title>
<p>Cranial irradiation impairs the maturation of dendritic spines by decreasing PAK3 signaling. Briefly, cranial irradiation increases miR-206-3p, which targets PAK3 and decreases its levels. Decreased PAK3 reduces the phosphorylation of LIMK and cofilin, resulting in decreased actin polymerization. This leads to a reduction in the ratio of F-actin to G-actin, which in turn impairs the maturation of dendritic spines. As a result, cognitive function is impaired via dendritic spines.</p></caption>
<graphic xlink:href="547296v1_figs6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</sec>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.89221.1.sa2</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ye</surname>
<given-names>Keqiang</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Chinese Academy of Sciences</institution>
</institution-wrap>
<city>Shenzhen</city>
<country>China</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Compelling</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Important</kwd>
</kwd-group>
</front-stub>
<body>
<p>This study suggests that PAK3 may play a critical role in cognitive function after cranial irradiation, highlighting a potential therapeutic target to mitigate the adverse effects of radiotherapy. The main finding is of significance, and the evidence is <bold>compelling</bold> to support their major conclusion. This is an <bold>important</bold> discovery providing novel insight into the molecular mechanism of how PAK3/LIMK/Cofilin signaling modulates synaptic spine morphology in response to irradiation.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.89221.1.sa1</article-id>
<title-group>
<article-title>Reviewer #1 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>Exposure to cranial irradiation (IR) leads to cognitive deficits in the survivors of brain cancer. IR upregulates miR-206-3p, which in turn reduces the PAK3-LIMK1 axis leading to the loss of F and G-actin ratio and, thereby, mature dendritic spine loss. Silencing miR-206-3p reverses these degenerative consequences.</p>
<p>Strengths:</p>
<p>
The authors show compelling data indicating a clear correlation between PAK3 knockdown and the loss of mature dendritic spine density. In contrast, overexpression of PAK3 in the irradiated neurons restored mature spine types and recovered the F/G ratio. These in vitro results support the authors' hypotheses that PAK3 and LIMK1-mediated downstream signaling impact neuronal structure and reorganization in vitro. These data were supported by similar experiments using differentiated human neurons. Importantly, silencing miR-206-30 using antagonist miR also reverses IR-induced downregulation of the PAK3-LIMK1 axis, preventing spine loss and cognitive deficits.</p>
<p>Weaknesses:</p>
<p>All the miR-206-3p data are presented from in vitro cortical neurons or human stem cell-derived neuron cultures. This data (IR-induced elevation of miR-206-3p) should also be confirmed in vivo using an irradiated mouse brain to correlate the cognitive dysfunction timepoint.</p>
<p>Antago-miR-206-3p reversed Ir-induced upregulation of miR-206 (in vitro), and prevent reductions in PAK3 and downstream markers. Importantly, it reversed cognitive deficits induced by IR. This data should be supported by in vivo staining for important dendritic markers, including cofillin, p-cofilin, PSD-95, F- and G-actin within the hippocampal and PFC regions.</p>
<p>Other neuronal and non-neuronal targets of miR-206-3p should be discussed and looked into as a downstream impact of IR-induced functional and physiological impairments in the brain.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.89221.1.sa0</article-id>
<title-group>
<article-title>Reviewer #2 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>
The paper entitled &quot;PAK3 downregulation induces cognitive 1 impairment following cranial irradiation&quot; by Lee et al. aimed at investigating the functional impact of cranial irradiation in mouse and propose PAK3 as molecular element involved in radiation-induced cognitive decrement. The results provided in this paper are problematic as both the irradiation paradigm (5X2 Gy) as well as the timing of investigation (3 to 8 days post-IR) are completely irrelevant to investigate radiation induced neurocognitive impairment. This testifies to the team's lack of knowledge in radiobiology/radiotherapy and the methodology to explore radiation induced neurocognitive damages. It precludes any further relevance of the molecular results.</p>
<p>Weaknesses:</p>
<p>
First and according to the BED equation a single dose of 10 Gy cannot not be approximated by 5 fractions of 2 Gy, as fractionation is known to decrease normal tissue toxicity. Note that in radiobiology/radio-oncology, the BED stands for &quot;Biologically Effective Dose.&quot; This equation is used to compare the effects of different radiation treatments on biological tissues, taking into account the dose, fractionation, and the overall biological response of the tissue to radiation.</p>
<p>
The BED equation is commonly used to calculate the equivalent dose of a fractionated radiation treatment, which is the dose that would produce the same biological effect as a single, higher dose delivered in a single fraction.</p>
<p>
The general formula for BED is:BED = D * (1 + d / α/β)</p>
<p>
D is the total physical dose of radiation delivered in Grays (Gy)</p>
<p>
d is the dose per fraction in Gy</p>
<p>
α/β is the tissue-specific ratio of the linear (α) and quadratic (β) components of the radiation response. It is measured in Gy and describes how the tissue responds to different fractionation schedules (usually equal to 3 for the normal brain).</p>
<p>
Please refers to radiobiology/radiotherapy textbooks by Hall or Joiner.</p>
<p>Second, the brain is a late responding organ. GBM patients treated with 60 Gy exhibit progressive and debilitating impairments in memory, attention and executive function several month post-irradiation. In mice, neurocognitive decrements after a single dose of 10 Gy delivered to the whole brain does occur at late time point, usually &gt; 2 months post-exposure. Multiple publications such as the one by Limoli C lab, Rossi S lab, Britten R lab or earlier Fike J lab and Robin M lab support this. Next, 5 fractions of 2 Gy will be more protective than a single dose of 10 Gy and neurocognitive decrements will require at least 5-6 months to occur if they ever occur. In Figure 1, the decrement reported is marginal, the number of animals included (4 to 5 at most?) The number of animals is not specified) is too low to draw any significant conclusions. In addition to the timing issue, the strategy described for NOR analysis shows methodological issues with the habituation period being too short and exploration level being very low.</p>
</body>
</sub-article>
</article>